Interleukin-2-tyrosine kinase substrate docking and its regulation by an intramolecular interaction in phospholipase Cg1 by Min, Lie
Graduate Theses and Dissertations Iowa State University Capstones, Theses andDissertations
2008
Interleukin-2-tyrosine kinase substrate docking and




Follow this and additional works at: https://lib.dr.iastate.edu/etd
Part of the Biochemistry, Biophysics, and Structural Biology Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Min, Lie, "Interleukin-2-tyrosine kinase substrate docking and its regulation by an intramolecular interaction in phospholipase Cg1"
(2008). Graduate Theses and Dissertations. 10590.
https://lib.dr.iastate.edu/etd/10590
Interleukin-2-tyrosine kinase substrate docking and its regulation
by an intramolecular interaction in phospholipase Cg1
by
Lie Min
A dissertation submitted to the graduate faculty
in partial fulfillment of the requirements for the degree of
DOCTOR OF PHILOSOPHY
Major:  Biochemistry
Program of Study Committee:








Copyright © Lie Min, 2008.  All rights reserved.
ii
TABLE OF CONTENTS
CHAPTER 1. GENERAL INTRODUCTION
General Introduction                                                                                                   1
Literature Review                                                                                                       3
Thesis Organization                                                                                                  24
References                                                                                                                 25
CHAPTER 2. A REMOTE SUBSTRATE-DOCKING MECHANISM FOR THE TEC
FAMILY TYROSINE KINASES
Abstract                                                                                                                     32
Introduction                                                                                                               33
Results                                                                                                                       34
Discussion                                                                                                                 39
Materials and Methods                                                                                              43
Acknowledgements                                                                                                   46
References                                                                                                                 52
CHAPTER 3. PHOSPHOLIPASE Cg1 PHOSPHORYLATION BY ITK IS MEDIATED BY   
A NON-CLASSICAL SH2 SURFACE
Abstract                                                                                                                    64
Introduction                                                                                                              65
Results                                                                                                                      67
iii
Discussion                                                                                                                  72
Methods                                                                                                                      76
Acknowledgements                                                                                                    77
References                                                                                                                  77
CHAPTER 4. A PHOSPHOLIPASE Cg1 INTRAMOLECULAR INTERACTION
REGULATES THE SUBSTRATE DOCKING INTERACTION
Abstract                                                                                                                    89
Introduction                                                                                                              89
Results                                                                                                                      91
Discussion                                                                                                                96
Materials and Methods                                                                                             99
Acknowledgements                                                                                                100
References                                                                                                              100
CHAPTER 5. INTERMOLECULAR SELF-ASSOCIATION INHIBITS THE ACTIVITY
OF INTERLEUKIN-2 TYROSINE KINASE
Abstract                                                                                                                   113
Introduction                                                                                                             114
       Experimental Procedures                                                                                         116
Results                                                                                                                     118
Discussion                                                                                                               125
References                                                                                                               128
iv
Acknowledgements                                                                                                 132
CHAPTER 6. GENERAL CONCLUSIONS
Summary                                                                                                                140
Future directions                                                                                                    142
References                                                                                                              145
ACKNOWLEDGEMENTS                                                                                               147
1CHAPTER 1. GENERAL INTRODUCTION
General Introduction
Interleukin-2-tyrosine kinase (Itk, also known as Tsk, Emt) was initially discovered in
a PCR-based molecular screen for tyrosine kinase family members that are implicated in
TCR signalng present in the thymus (1-3).  Along with Btk, Tec, Rlk and Bmx, Itk belongs to
the Tec kinase family, the second largest non-receptor tyrosine kinase family (3-5).  Tec
family kinases are primarily expressed in hematopoietic lineage with the exception of Tec
and Bmx, which are also found in endothelial cells.  Itk and Rlk are expressed in T cells,
mast cells and NK cells. Tec is also expressed in T cells, although the expression level of Tec
is lower than that of Itk and Rlk. Btk is expressed in all hematopoietic cells except T cells
and plasma cells.
Tec family kinases play important roles in hematopoietic cells development and
function.  The importance of Tec family kinases has been emphasized by the fact that genetic
mutations in Btk is linked to X-linked agammaglobulinemia (XLA) in human and X-linked
immunodeficiency (XID) in murine, which is characterized by reduced serum
immunoglobulin and defective B cell development and function (6, 7).  Itk has played an
important role in TCR signaling.  Itk-/- mouse showed defective TCR signaling including
reduced proliferation, IL-2 production, and production of effector cytokines (8-10).  Recently
it is found that Itk-/- or Itk-/- Rlk-/- mice showed impaired thymic development and altered
mature T cell effector functions (10-13).  Growing evidence indicate that Itk also plays an
important role in cytoskeletal reorganization and thus, regulates the formation of the
immunological synapse (14-16).
2The Tec family kinases share a similar domain structure with the Src family kinases
with one Src homololy 3 (SH3) domain, one Src homology 2 (SH2) and a catalytic domain
(Figure 1) (17).  However, the presence of the N-terminal Pleckstrin homology (PH) domain
in Tec family kinases (except Rlk) and lack of the C-terminal phosphorylation tail make Tec
family kinases disctinct from Src family kinases. The Tec family kinases also include a
unique TH (Tec homology) domain and proline rich (PR) motif.   The structures of the
individual Itk domains except the PH domain have been determined (18-20).    The PH-TH
domain structure of Btk has been solved (21, 22).
The non-catalytic PH, SH3 and SH2 modules mediate different protein-protein and
protein-lipid interactions.  In addition to mediating the intramolecular interaction with the PR
motif, the Itk SH3 can also can interact with the SH2 domain in a non-classical manner (23).
In my thesis, I extended this domain-domain interaction to the full-length Itk molecules and
Figure 1. Src and Tec family kinases domain structure.
3presented data suggesting self-association of Itk can downregulate Itk kinase activity both in
vitro and in primary T cells.
During TCR signaling, Itk phosphorylates its substrate PLCg1 (5, 24).  This
phosphorylation activates PLCg1, which can hydrolyze PIP2 into inositol 1, 4, 5-triphosphate
(IP3) and diacylglycerol (DAG) (25).   In my thesis, I define the mechanism by which Itk
phosphorylates PLCg1 and show that a substrate docking interaction is required for efficient
phosphorylation of both a PLCg1 fragment and the full-length molecule.  I also show that the
docking interaction can be regulated by an intramolecular interaction within PLCg1. These
studies provide insight into the mechanism of Itk substrate recognition and TCR signaling
regulation.
Literature Review
Huge progress has been made in understanding the function of Itk in the two
signaling pathways that involve Itk, the TCR signaling pathway and TCR engagement
induced cytoskeletal reorganization.  Due to the development of X-ray and NMR methods,
the structural studies at the molecular level contributed greatly to the understanding of Itk
function in the last decade.
Tec kinase structural features: PH domain
PH domains are the 11th most prevalent domains in the human genome (26) and they
were first identified as structural modules that contain 100-120 amino acid residues.  Proteins
typically contain one or two copies of the PH domain and some proteins contain split PH
4domains.  Phospholipase Cg contains two PH domains, with one split PH domain with two
halves flanking tandem SH2 domains and a SH3 domain (Figure 2).
PH domains participate in cellular signal transduction through binding to
phosphoinositides and then recruiting their host proteins to the cell membrane (26). For
example, Tec family kinase PH domains specifically recognize the phosphoinositol-3-kinase
(PI3K) product, phosphatidylinositol (3, 4, 5)-trisphosphate [PtdIns (3, 4, 5) P3] and then
cause Tec kinase family members to associate with the cell membrane in a signaling
dependent manner.  However, recent studies in yeast indicate that only a small fraction of
known PH domains bind phosphoinosides and most of these PH domains bind
phosphoinositides with only low affinity and with little-to-no specificity (26). These studies
suggeste that PH domains may have binding targets other than phosphoinositides and their
function is much more diverse than previously supposed.
Many protein ligands have been reported for PH domains aside from the
phosphoinositides.  Yao and coworkers reported that the Btk PH domain can interact with F-
actin, which is important for the co-localizaiton of Btk with actin filaments and also actin
reorganization after receptor cross-linking (27).  So far it has been reported that the Btk PH
domain can interact with bg subunits of G proteins (28), protein kinase C isoforms (29), and
Fas (30).  Kim and coworkers presented evidence to suggest that the PH domain of another
Tec kinase family member, Bmx/Etk, can interact with the small GTPase RhoA and activate
Figure 2. PLCg domain structure. Adapted from ref. 80
5RhoA (31).  Evidence also indicates that the Etk PH domain can interact with focal adhesion
kinase (FAK) (32).  Therefore, the PH domain might play a diverse role by mediating many
different protein-protein and protein-lipid interactions in cellular signaling transduction.
PH domain structures from many proteins have been solved, including the Btk PH
domain (21, 22).  All of these PH domains, including the split PH domains (33), share similar
three-dimensional structures with a seven-stranded bent b-sheet with a C-terminal a-helix
closing one end of the core b barrel (34).  Structures of several PH domains complexed with
different phosphorylated ligands (inositol phosphates or phosphatidylinositol lipids) indicate
the phospholipid binding site is not conserved in these domains (34).  But all of these PH
domains showed remarkable electrostatic polarization.  The positively charged part of PH
domains is involved in interaction with the negatively charged inositol phosphate.  Removal
of the positive charge in the binding pocket can significantly decrease the binding affinity of
PH domain for phosphoinositides and introducing positively charged residues in the binding
pocket can increase the binding affinity of PH domain for phosphoinositides.  Removing a
positive charge in Btk PH domain by mutating R29 to Cys destroys the interaction of PH
domain with the phosphoinositides and leads to the failure of Btk membrane association (21,
35).  Mutations in the Btk PH domain that lead to XLA, which is characterized by reduced
serum immunoglobulin and defective B cell development and function (6, 7), are clustered at
the positively charged end of the molecule around the predicted binding site for
phosphatidylinositol lipids.  On the other hand, increased positive potential in the gain-of-
function mutant E41K leads to increased affinity for phosphatidylinositol lipids and
constitutive association with the membrane and thus the activation of Btk (22, 35).
6Tec kinase structural features: SH3 domain
SH3 domains are small binding modules that contain approximately 60 amino acids
and are ubiquitous in eukaryotes.  SH3 domains are found in many proteins that are involved
in cellular signaling and cytoskeletal rearrangments.  The function of the SH3 domain is to
participate in cellular signal transduction by controlling protein-protein interactions.  SH3
domains, including Itk SH3 domain, share conserved three-dimensional structures, consisting
of two short b sheets that are packed against each other approximately at right angles (18,
36).  Each b sheet is composed of two anti-parallel b strands and prominent connecting
loops—termed the RT loop and n-Src loop.
The canonical interaction ligands for SH3 domains are proline rich motifs with the
consensus sequence of PxxP (P stands for Proline and x is any amino acid), which form a
left-handed polyproline-II helix (PPII) conformation in which the two invariant proline
residues are found on the same face of the peptide and participate in hydrophobic contacts
with conserved aromatic residues formed by the RT-loop and n-Src loop in the SH3 domain.
The PxxP motif can bind SH3 domains in two different orientations. Based on the relative
orientation of the basic residues to the core PxxP motif, the ligands can be classified as class
I and class II.  Class I proline rich ligand therefore have the consensus (R/K) xxPxxP and
class II proline rich ligand have the consensus PxxPx(R/K). Residues that flank the PxxP
motif can modulate the specificity and affinity of SH3/PxxP interaction not only by
providing additional binding energy through electrostatic interaction with residues in the
specificity pocket (a conserved Asp or Glu in RT loop of many SH3 domain), but also by
orienting the ligand with respect to the binding groove on the SH3 domain (37).
7In addition to interact with the PxxP motif, a large number of SH3 domains can also
interact with the proline rich motif in a different manner.  All Tec family kinases except the
Bmx/Etk possess the proline rich motif right next to the SH3 domains (figure 1).  Andreotti
et al. reported Itk SH3 domain could bind proline rich motif in an intramolecular manner
(18).  Extensive structural studies also showed that Tec family kinase regulatory domains
self-associate intermolecularly through the SH3/proline rich motif interaction in Rlk, Btk and
Tec (38, 39).
SH3 domains can also participate in interactions with ligands that lack the canonical
proline rich motif. For the Src family kinases, the SH3 domains interacts with the linker
connecting SH2 domain and the kinase domain in an intramolecular manner (40).  There is
only one proline in the linker but it nevertheless forms a left-handed helix. Mutation of SH3
domain residues in the binding pocket leads to deregulated kinase activity (40).
Tec kinase structural features: SH2 domain
SH2 domains are structural modules that are made up of approximately 100 amino
acids, conserved from yeast to eukaryotes, found in many proteins that are involved in
different cellular signaling pathways including mitogenesis, motility, metabolism, immune
response and gene transcription (41).  Among these signaling pathways those mediated by
protein kinases and protein phosphotases are the best characterized.  SH2 domain mediated
interactions can regulate enzyme activity in the interaction partner or by promoting protein-
protein interactions (42).
All SH2 domains share a conserved three-dimensional structure with a central b sheet
flanked by an a helix at each side (43).   The best characterized ligand for SH2 domains are
8phosphor-tyrosine (pY) containing sequences, which are critical for regulating the activity of
many protein kinases and many protein-protein interactions.  SH2 domains form two binding
pockets, one for the phosphor-tyrosine and the other one for the residues at the C-terminal of
the phosphor-tyrosine (the pY+3 residue).  The universally conserved Arg in the binding
pocket can bind phosphor-tyrosine by making a bidentate ionic interaction with two oxygens
of the phosphate group (44, 45).  The hydrophobic contact between the pY+3 side chains and
the binding pocket can modulate the specificity and affinity of SH2/phosphor-tyrosine
interaction.
Accumulating evidence indicates that many SH2 domains are also involved in
interactions with binding partners that lack the phosphor-tyrosine motif.  Our group
previously reported that Asn 286-Pro 287 imide bond in the Itk SH2 domain adopts both the
cis and trans conformation in solution (46).   The isomerization of the cis and trans
conformer regulates the ligand binding ability of the conformers (47).  The cis conformer
binds the Itk SH3 domain with higher affinity and the trans conformer binds phosphorylated
SLP-76 with higher affinity.  The noncanonical interaction surface between the Itk SH2
domain and the Itk SH3 domain has been mapped (46).  The CD loop in the SH2 domain and
the conserved hydrophobic binding pocket in Itk SH3 domain are implicated in the
interaction.  Consistent with the selective ligand interaction, NMR structure analysis
indicates that the cis and trans conformers share similar three-dimensional structures with the
exception of the CD loop (19).  The noncanonical interaction of Itk SH2/SH3 domain can
lead to dimerization/oligomerization of the larger fragment that contains both the SH3 and
SH2 domains (23).
9So far there are three SH2 domains have been directly implicated in human disease,
signaling lymphocyte activation molecule (SLAM)-associated protein (SAP) SH2, Btk SH2
and N-terminal SH2 domain of the nonreceptor protein tyrosine phosphoatase 2 (SHP-2)
(48).  Although the number of SH2 domains that are directly involved in disease is few, the
importance of SH2 domains in signaling transduction makes it desirable to design some
inhibitor or antagonist to selectively target specific proteins to alter specific signal
transduction pathway.  The availability of large numbers of high-resolution SH2 domain
structures complexed with pY ligand and the importance of SH2/pY interaction laid the
foundation to screen minimally sized phosphopeptide ligand of approximately 4-6 residues
that can efficiently bind specific SH2 domains to selectively inhibit cellular signal
transduction pathway in deregulated cells (41).  In the last decade significant
accomplishments have been made in Src SH2, Grb SH2 and Zap 70 SH2 domains drug
discovery (41).  The discovery of noncanonical interaction ligand for SH2 domains
potentially provides another template for designing new inhibitor drugs.
Tec kinase structural features: kinase domain
Kinase domains are the catalytic domains of protein kinases that transfer the g-
phosphate group from ATP to a specific hydroxyl group in the substrate, affecting
conformation and activity.  The human genome encodes ~500 kinase genes, which is about
1.7% of all human genes, and ~100 of them are protein tyrosine kinases (49).  Protein
tyrosine kinases mediate many of the cellular signaling transduction pathways and control
many cellular process.  Depending on the cellular localization, there are receptor tyrosine
kinases and non-receptor tyrosine kinases.  Tyrosine kinase activities are strictly regulated by
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complicated mechanism and loss of regulation will lead to severe disease like cancer,
inflammation and autoimmune disease, which makes kinases important drug targets (50).   
Biochemical analysis and structural characterization of kinase domains alone and/or
full-length tyrosine kinases in both active and inactive conformation have provided
significant insight into the mechanism of kinase regulation.  All kinase domains share a
conserved bilobal protein kinase domain fold and are composed of a smaller N lobe, and a
larger C lobe (51).  N lobes consist of five b strands and a critical a helix.  C lobes consist of
mainly a helix and an activation loop.  In many tyrosine kinases, the activation loop needs to
be phosphorylated to switch the enzyme to its active conformation. The N lobe and C lobe
are connected by a loop, which forms a cleft for nucleotide binding and phosphotransfer.
Src family kinase regulatory mechanisms are one of the best-characterized regulation
systems.  Accumulating evidence indicates that Src kinase activity could be regulated by
several key structural features (51, 52): the orientation of the helix C in the N-lobe,
phosphorylation status of the activation loop, the relative orientation of the N lobe and C
lobe, and intramolecular interactions with the Src homology domains.  The Src SH2 domain
interacts with the C-terminal phosphorylated Y527 tail in an intramolecular manner.  As
already mentioned above, the Src SH3 domain can also interact with the linker between the
SH2 domain and N lobe of the kinase domain, which contains one proline yet still forms a
polyproline type II helix.  The intramolecular interactions mediated by the SH2 and SH3
domains lock the kinase domain in a rigid and inactive conformation (53-55).  Importantly,
these intramolecular interaction ligands don’t possess canonical interaction ligand property
and therefore are not high-affinity ligands (51).  When the SH2 and SH3 domain mediated
intramolecular interactions are disengaged, helix C will be reoriented into an active
11
conformation for substrate binding through forming a conserved ion pair between Glu 310
(residue from helix C) and Arg 285 (Src numbering).  The reorientation of helix C and
phosphorylation of the activation loop are coupled (52).  When the kinase domains are in an
inactive conformation, the activation loop adopts a helix conformation and blocks the
phosphorylation of Y416 and the access of substrate peptide.  When Y416 is phosphorylated
and helix C adopts an active conformation, the kinase become fully active (51).
Phosphorylation of the activation loop leads to a conformational change in the
activation loop and concurrent activation of the kinase is a conserved regulation mechanism
in Src family kinases.  However, analysis of the crystal structures of Tec family kinase Itk
indicates that the Tec family kinases might be regulated by a different mechanism.  Crystal
structures of the Itk kinase domain in both phosphorylated and unphosphorylated states have
been solved (20).  The Itk kinase domain shares the conserved bilobal structure and is similar
to structures of the active states of many other kinases.  Surprisingly, there is no significant
conformational difference between the phosphorylated states and the unphosphorylated states
in Itk.   A structure has been solved for the kinase domain of another Tec family member,
Btk.  The Btk kinase domain structure corresponds to the unphosphorylated form (56).
Overall, the Btk kinase domain structure is very similar to that of the phosphorylated Lck
kinase domain except for helix C which is in an inactivated conformation (57).  What is
noteworthy is that the activation loop in the Btk kinase domain adopts an open conformation
similar to that of Lck without limiting the access of substrate.  However, biochemical data
clearly indicated that transphosphorylation of Y551 (Btk) and Y511 (Itk) are critical for
enzyme activation both in vitro and primary T cells (58-60).  Therefore regulation
12
mechanism of Tec family kinases is different from that of Src family kinases and exerted by
both the catalytic and the regulatory domains coordinately.
TCR signaling pathway and the role of Itk
Itk is involved in the downstream signaling pathway of various T cell receptors such
as TCR (T cell receptor)/CD3, CD28 and CD2 (61).  Among these receptors, the TCR
signaling pathway is the best understood.  TCR is a transmembrane protein composed of
heterodimer a and b subunits, which are covalently linked to each other by a disulfide
bridge. TCR a and b chains are noncovalently associated with CD3 gd, ed, and TCR
z proteins (Figure 3) (62, 63).   Each of the CD3 g, d, e cytoplasmic domains contains a
conserved immunnoreceptor tyrosine-based activation motif (ITAM) with the consensus
sequence YxxL(x) 6-8YxxL and the z chain contains three ITAM motifs. Each ITAM motif
contains 2 tyrosines and there are total 10 ITAM motifs for all the CD3 chains and z chain.
TCR has no intrinsic kinase activity. When TCR binds the peptide/MHC (major
histocompatibility complex) complex in APC (antigen presenting cells), co-receptor CD4 or
CD8 bind different regions of the MHC complex at the same time, which also brings the
associated Src family kinase, Lck into the cluster and activates Lck at the same time.  Lck
can phosphorylate Tyr in the ITAM motifs and then the phosphorylated ITAM motif in the
z chain will become a docking site for the Syk family tyrosine kinase ZAP-70 through the
canonical SH2/phosphotyrosine interaction.  After ZAP-70 is enrolled to the cluster, ZAP-70
can be phosphorylated and activated by Lck.  Activated ZAP-70 in turn can phosphorylate
downstream signaling molecules.  Linker for activation of T cells (LAT) and the SH2-
domain-containing leukocyte protein of 76 kD (SLP-76) are two adaptor proteins, both of
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which can be phosphorylated by ZAP-70 and then they can serve as platforms for recruiting
other signaling molecules like the adaptors Grb-2, GADS and Nck, the guanine-nucleotide-
exchange factor (GEF) Vav1, and PLCg1 (17, 24, 64) (Figure 4) . Lck can also
phosphorylate and activate phosphoinositide 3-kinase (PI3K), which will catalyze the
formation of phosphatidylinositol (3, 4, 5)-trisphosphate [PtdIns (3, 4, 5) P3].  Itk can
translocate to the plasma membrane by interacting with PtdIns (3, 4, 5) P3 through its PH
domain (4, 5) as described above.   When these molecules are all localized to the membrane,
they will form a multimolecular signaling complex.  Itk is then phosphorylated and activated
by other mechanisms, which are described in detail later in this introduction.
When Itk is activated, Itk can phosphorylate its substrate PLCg1 (5).  When PLCg1 is
phosphorylated and activated by Itk, it hydrolyzes PIP2 into inositol 1, 4, 5-trisphosphate
(IP3) and diacylglycerol (DAG) (25).  Then IP3 and DAG can stimulate cytosol Ca
2+ increase




Figure 3. Schematic illustration of TCR. Adapated from reference 63.
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regulate T cell gene expression through the activation of Ras-Raf-ERK (extracellular
receptor-activated kinase) pathway.
TCR engagement induces cytoskeleton reorganization
Cytoskeletal reorganization is the second pathway involving Itk that occurs following
TCR engagement (14-16).  After the TCR complex recognizes a particular MHC-associated
peptide on an antigen presenting cell (APC), several T cell surface proteins and intracellular
signaling molecules are rapidly mobilized to the site of T cell-APC contact.  Concurrently, F-
actin started to accumulate at the site of contact with the APC, which will lead to cell
polarization.  The physical contact region between the T cell and APC is called an
immunological synapse (IS), or a supramolecular activation cluster (SMAC).  The formation
of the synapse is not required for initial TCR activation and protein phosphorylation, but the
Figure 4. T-cell receptor signaling to cytoskeleton.  Adapted from reference 17.
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synapse formation is important for prolonged and effective T cell signaling (65).  The affinity
between TCR and peptide-MHC complexes is low therefore the enrichment of adhesion
molecules in the synapse will facilitate the binding of TCR to APCs promoting repeated
engagement of the TCR.
Itk is implicated in actin cytoskeleton regulation, which is necessary for cell adhesion
and formation of the immune synapse in T lymphocyte (66).  Itk deficient T cells or Jurkat T
cells with diminished Itk expression level showed disrupted TCR-induced actin polarization
and deficiency in immunological synapse formation.  Compared with decreased efficiency in
PLCg phosphorylation and Ca2+ mobilization, the defect in actin polymerization and
formation of the immunological synapse after antigen stimulation indicates that Itk plays an
essential role in cytoskeleton reorganization.  Therefore Itk regulates cytoskeletal
reorganization and through which regulates the formation of the immunological synapse and
duration of TCR signaling.
The molecular mechanism of Itk regulating actin cytoskeleton is not clear. There is
research indicating that this function of Itk is not dependent on Itk kinase activity since the
TCR induced actin cytoskeleton defect in Itk-/- or Itk expression level diminished mice can be
rescued by the expression of an Itk kinase inactive mutant (14). This function is related to the
PH domain and canonical function of Itk SH2 domain, but not the Itk SH3 domain (16).  Tec
kinases might also play a critical role in TCR-mediated regulation of integrin adhesion and
the recruitment of key signaling proteins involved in adhesion, including LFA-1 and talin
(66).
WASP (Wiskott-Aldrich syndrome protein) is another component in the actin
signaling pathway and mutation of WASP will lead to abnormal T cell cytoskeleton
16
organization (17).  WASP can interact with the Rho family GTPase Cdc42, which will
induce large conformational changes in WASP and also activate WASP.   Itk deficient T
cells show a profound defect in Cdc42 activation and WASP activation in the immunological
synapse (15). Therefore Itk is required for recruitment and activation of both Cdc42 and
WASP at the immunological synapse. Itk can also directly regulate and phosphorylate WASP
(15).
Vav-1 is another protein that is rapidly phosphorylated after TCR engagement.  Vav-
1 can be activated by phosphorylation then Vav-1 acts as a GEF factor for the Rho family
GTPases Rac, Rho and Cdc42.  Vav-1 plays an important role in the signaling pathway that
regulates actin cytosekeleton after TCR engagement (17).  Vav-1 deficient T cells showed
defective TCR mediated actin polymerization and cell adhesion.  Itk-/- T cells showed
defective TCR induced actin polymerization and also total abolishment of Vav-1 recruitment
although for both wild type T-cells and Jurkat T cells Vav-1 is recruited to the synapse.
Similar results were obtained when Vav-1 DNA and siRNA oligonucleotides for inhibiting
Itk expression were cotransfected into Jurkat T cells.  Therefore, the other pathway by which
Itk regulates actin cytoskeleton reorganization is through regulating the localization of Vav-
1.  Mombroski and coworkers showed that expression of membrane targeted Vav-1 can
rescue the siRNA for Itk induced defective actin cytoskeleton (14) and this data supported
the regulatory role that Itk played in regulating actin cytoskeleton through Vav-1.  The
molecular mechanism is not clear.  There is evidence showing that there is constitutive
association between Vav-1 and Itk, although it is not clear whether the association is direct or
indirect (14).  Both Vav-1 and Itk can interact with SLP-76 through their SH2 domains.
17
Therefore it is possible that Itk can regulate Vav-1 localization by affecting the ability of
Vav-1 to interact with SLP-76 (or LAT).
Initial Itk activation mechanism
When the TCR is engaged, Itk will be phosphorylated and activated within 120
seconds (67).  Itk activation requires two events: membrane translocation through PH domain
binding to the product of phosphoinositide 3-kinase, then transphosphorylation by the Src
family kinase Lck.  Phosphatidylinositol 3-kinase inhibitor can inhibit Itk membrane
localization and therefore Itk phosphorylation and activation (68, 69).  The PH domain is
more than just a membrane translocation signal in Itk activation since Itk membrane targeting
through membrane localization signal found in the N-terminus of Lck can reconstitute its
inducible colocalization with TCR-CD3 but not its tyrosine phosphorylation and activation
(70).
After TCR engagement, Itk participates in a multimolecular signaling complex, which
includes LAT, Grb2, SLP-76, and PLCg1.  Itk will be recruited to the signaling complex by
multivalent protein-protein interactions (71).  The Itk proline rich region can bind Grb2 and
LAT; both Itk SH3 and SH2 domain can interact with phosphorylated SLP-76.  These
multiple interactions are critical for proper localization of Itk and TCR signal transduction.    
After Itk is recruited to the multimolecular signaling complex, Itk can be
phosphorylated by the Src family kinase Lck at Y511 (60). Y511 is a conserved
phosphorylation site in the activation loop of Tec family kinases kinase domain (Y551 in
Btk) and the phosphorylation of Y511 is critical for the kinase activity of Tec family kinases
(58, 59). When Btk Y511 is phosphorylated, kinase activity will be enhanced about 10 times.
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Itk Y511F leads to total abolishment of Itk kinase activity in insect cells.  Itk Y511F can’t
rescue cytokine production and ERK activation in Itk deficient T cells while wild type Itk
does (60).
When Itk is phosphorylated at Y511, Itk becomes active and phosphorylates its own
SH3 domain at Y180 (72).  Itk autophosphorylation occurs in cis manner although there is
evidence indicating that Itk can oligomerize (73-75).  In vitro kinase assays indicate that
autophosphorylation on Y180 does not change Itk intrinsic kinase activity but instead
changes the ability of the Itk SH3 domain to recognize substrates and participate in protein-
protein interactions with ligands (74).  This result provides an explanation for the early report
that Itk Y180F has only partial activity in rescuing cytokine production and ERK
phosphorylation in Itk deficient T cells (74).  This is also consistent with the previous report
that when the Btk SH3 domain is autophosphorylated, its ligand binding properties are
altered compared to the nonphosphorylated protein (76, 77).
Itk kinase activity regulation mechanism
It is well known that intramolecular interactions mediated by SH3 and SH2 domains
maintain Src family kinases in an inactive state (40, 51, 52).  However the mechanisms that
regulate Itk kinase activity are not clear.  A detailed regulation mechanism of Itk (or Tec
family kinase) is still awaiting elucidation of full-length molecule structure.  Based on
domain studies, Itk SH3 and SH2 domains can mediate multiple interactions.  The Itk SH3
domain can interact with its own PR motif in an intramolecular manner and this interation
can also affect the ability of Itk SH3 domain to interact with other ligands (18).
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In addition to interacting with the Itk proline rich region, Itk SH3 domain can also
interact with its own SH2 domain in an intermolecular manner (23).  The interaction between
Itk SH2 and SH3 domains leads to dimerization/oligomerization of the Itk molecule, which
seems to be a conserved feature in Tec family kinases although the
dimerization/oligomerization is mediated by different domains for the different Tec kinases
(38, 39).  In the larger fragment that contains Itk proline rich region, SH3 and SH2 domains
or full-length Itk, the intermolecular interaction mediated by Itk SH3 and SH2 domains
seems to dominate over the intramolecular PxxP motif/SH3 interaction.  We have shown that
dimerization/oligomerization can decrease Itk kinase activity and mutations that diminish the
dimerizatio/oligomerization enhances Itk kinase activity both in vitro and in vivo (Lie Min,
Amy H. Andreotti, submitted to JBC, see Chapter 5), which has been talked in the Chapter 5.
This is consistent with the results that deletion of TH domain in full-length Itk leads to
decreased Itk kinase activity and deletion of Itk SH3 domain leads to increased Itk kinase
activity (78).
Itk kinase activity can also be regulated by interaction with regulating ligands.
Recently our group reported a novel substrate docking interaction that is mediated by the Itk
kinase domain and substrate SH2 domains (Itk SH2 domain or PLCg1 SH2C) (79).  This
substrate docking interaction is necessary for substrates to be efficiently phosphorylated.
This interaction is distinct from most SH2 domains mediated interactions and it is not
dependent on phosphor-tyrosine ligand.  The data describes this regulatory mechanism is
presented in Chapters 2 and 3.
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PLCg1
PLCg1 is a phospholipase that hydrolyzes PIP2 into IP3 and DAG.  PLCg1 belongs to
the phosphoinositide-specific phospholipase C (PI-PLC) family, which includes six families
and 14 mammalian PLC isozymes.  These are PLCb (b1-b4), PLCg (g1-g2), PLCd (d1-d4),
PLCe, PLCz and PLCh  (h1-h2) (Figure 5) (80, 81).  These PLC isozymes contain very
different combinations of structural modules but all contain the conserved catalytic domain X
and Y.  Among these family members, PLCg is the best characterized.  PLCg2 is expressed in
B cells while PLCg1 is expressed ubiquitously.  PLCg1 can be activated by many different
growth factor receptors like platelet-derived growth factor (PDGF), epidermal growth factor
(EGF), fibroblast growth factor (FGF), hepatocyte growth factor (HGF), nerve growth factor
receptor (NGF) (82) and T cell receptor (83).  PLCg1 plays an important role in cell
proliferation and differentiation.  PLCg1 deficiency is early embryonic lethal because of
defects in growth and development (84).
Figure 5. Schematic illustration of mammalian phospholipase C (PLC) isozymes.
Adapted from reference 80.
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PLCg consists of an amino terminal PH domain, a number of EF hands, catalytic
domain X and Y splited by a PH domain (80, 83).  There is a large regulatory SH domain
insert composed of N-terminal SH2 (SH2N), C-terminal SH2 (SH2C) and SH3 domain
within the second PH domain.  The SH2 domains mediated interaction is important for
phosphorylation and activation of PLCg1 (85-87).  SH3 domain mediated interactions play an
important role in many cellular processes like cell motility, proliferation, and development
that implicate PLCg1 (88-90).
Src Homology domains can also regulate PLCg1 activity.  Homma and coworkers
reported that the protein fragment that includes the PLCg1 SH2N, SH2C and the SH3
domains can inhibit PLCg1 activity in trans and this inhibition derives primarily from a 8-
mer peptide in the SH2C (91).  Consistent with this, Carpenter and coworkers reported that
deletion of the SH domains leads to 20- to 100- fold increase in PLCg1 activity (92).  Koblan
and coworkers reported that a phosphotyrosine ligand could cause conformational changes in
PLCg1 and also increase lilpase activity up to 85% (93).
The other important factor that regulates PLCg1 activation is tyrosine
phosphorylation.  There are four phosphorylation sites in PLCg1, Y771, Y775 (94), Y783 
and Y1253 (95).  The phosphorylation level of Y771 is about 10% that of Y783 and is
considered a minor phosphorylation site.  The first three tyrosines are located in the linker
between SH2C and SH3 and the phosphorylation of these three tyrosines can be detected in T
cells after antigen stimulation but not the phosphorylation of Y1253, which can be detected
in cells that are stimulated with PDGF or EGF (95).  Phosphorylation of Y783 is essential for
the activation of PLCg1, while the mutation of Y771 and Y1254 has no effect of the
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phosphorylation and activation of PLCg1 (80, 94).  After Y783 is phosphorylated, PLCg1 is
thought to undergo conformational change to form an intramolecular interaction between
PLCg1 SH2C and phosphor-Y783, which leads to increase in phospholipase activity of
PLCg1 (96).  The newly identified Y775 is also important for PLCg1 function (94).
By mutating the canonical phosphor-tyrosine binding pocket in the SH2 domains,
numerous studies found that SH2N is required for membrane recruitment and tyrosine
phosphorylation of PLCg1, while the SH2C is not critical for this event (86, 87).  Rellanhan
and coworkers found that SH2C could interact with phosphorylated LAT and BLNK with the
same affinity in vitro as SH2N and it can also interact with nonphosphorylated peptide from
LAT (97). However, it is reported that mutation of the conserved Arg binding pocket in
SH2C was not required for full length PLCg1 mediated interaction in vivo (86, 87). These
data suggest that an interaction surface in SH2C is possibly buried in full length PLCg1
before phosphorylation and activation.  The fact that SH2C but not SH2N can interact with a
nonphosphorylated peptide also suggests that SH2C at least mediates noncanonical ligand
interactions.  Thus, the commonly used criteria for judging SH2 domain function by mutating
the conserved phosphor-tyrosine ligand binding pocket might be misleading and complicate
the interpretation of SH2 domain function.
Substrate docking
Kinases and phosphatases are two key pairs of enzymes that control the signal
transduction processes in the cell.  Thus, it is critical to control not only the activity of these
signaling proteins but also the specificity of these enzymes.  One common strategy that
tyrosine kinases/phosphatases utilize is to exploit protein-protein interaction modules like the
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SH2 or SH3 domain, which are often fused to the core catalytic domain (98).  Another
strategy that Ser/Thr kinases/phosphatases use is a substrate docking mechanism in which the
catalytic domain harbors a substrate-binding surface that is distinct from the catalytic site
(98).   
The substrate docking mechanism is well characterized in serine/threoline
kinase/phosphatases such as PP1 and calcineurin, MAP kinase, CDD/cyclins, PDK1 and
GSK3 (98).  The structural bases for many of these docking interactions have been described.
Structure data and mutagenesis analyses indicate that in most docking interactions linear
peptides motifs within substrates are recognized by a groove in the catalytic domain (98).
C-terminal Src kinase (Csk) is the first tyrosine kinase for which a docking
interaction is required to phosphorylate its substrate Src or Yes has been described (99, 100).
Recently, our group found that the Tec family kinases also utilize a specific docking
interaction to phosphorylate its substrates (79).  This work is described in detail in Chapters 2
and 3.
Deregulation of kinases/phosphatases often leads to diseases like cancers; therefore
the discovery of specific kinases/phosphatase inhibitors is essential for therapeutic
application to combat such diseases.  To date, the most common kinase inhibitors target the
conserved ATP binding site.  Despite some success in industry, similar structure of the kinase
ATP binding site makes this type of drug inherently cross-reactive.  Therefore, targeting an
enzyme/substrate docking interaction provides another approach for developing small
molecules that could affect enzyme activity by modulating protein-protein interactions rather
than targeting an active site.  Small molecule inhibitors of this type have been successfully
screened for the calcineurin-NFAT interaction (101).  As well, it has been reported that
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peptide inhibitors containing the appropriate docking motif can selectively modulate MAPK
and PP1 activity in vivo (102).  These results indicate that structural and biochemical studies
to define substrate docking interactions have the potential to lead to the discovery of specific
and useful drugs.
Thesis organization
This thesis includes six chapters: a general introduction (Chapter 1), followed by four
chapters (Chapter 2-5 describe scientific results) and a general conclusion (Chapter 6).  The
literature review in Chapter 1 contains the necessary background information and current
status of the cellular singaling pathway of Itk, initial activation of Itk and its domain features.
Chapter 2, which has been published in a peer-reviewed journal, describes a substrate
docking mechanism in the Tec family kinases.  Chapter 3, which is a manuscript in
preparation for submission, extended the substrate docking mechanism discovered in Chapter
2 to full length PLCg1.  Chapter 4, which is ongoing work and will be published upon the
determination of the PLCg1 SH2C-linker complex structure, shows that this docking
interaction can be regulated by an intramolecular interaction within PLCg1.  Chapter 5,
which has been submitted for publication, presents data suggesting that the self-association
of Itk can downregulate Itk kinase activity in vitro and in primary T cells.  The general
conclusion chapter (Chapter 6) includes a summary of the research work and future
directions of study.
As primary author, I carried out most of the experiments in this thesis. In Chapter 2, I
performed all PLCg1 related experiments and Dr. Raji E. Joseph obtained data for the Itk
SH3 domain.  I perfomed all of the experiments described in Chapter 3 and 4.  In Chapter 5, I
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performed the all of the biochemical experiments and Dr. Wenfang Wu (University of
Massachusetts Medical School) obtained the data from insect cells and primary T cells. In
addition, Chapters 2-5 benefited greatly from discussion with Dr. Amy H. Andreotti, Dr. D.
Bruce Fulton, and Dr. Raji E. Joseph.
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Abstract
During T cell signaling, Itk selectively phosphorylates a tyrosine within its own SH3
domain and a tyrosine within PLCg1.  We find that the remote SH2 domain in each of these
substrates is required to achieve efficient tyrosine phosphorylation by Itk and extend this
observation to two other Tec family kinases, Btk and Tec.  Additionally, we detect a stable
interaction between the substrate SH2 domains and the kinase domain of Itk, and find that
addition of specific, exogenous SH2 domains to the in vitro kinase assay competes directly
with substrate phosphorylation.  Based on these results, we show that the kinetic parameters
of a generic peptide substrate of Itk are significantly improved by fusing the peptide substrate
to the SH2 domain of PLCg1.  This work is the first characterization of a substrate docking
mechanism for the Tec kinases and provides evidence for a novel, phosphotyrosine-
independent regulatory role for the ubiquitous SH2 domain.
KEYWORDS Itk substrate docking, SH2 domain, phosphotyrosine-independent, Tec kinases
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Introduction
Transfer of the g-phosphate group of ATP to amino acid side chains is a primary mechanism
of cellular signal transduction and is carried out by a large family of enzymes termed the
protein kinases.  The manner in which substrate recognition is achieved by the myriad of
protein kinases is not completely understood but it is clear that specificity determinants can
be outside of the motif immediately surrounding a particular phosphorylation site.  Docking
sites have been characterized for a number of protein kinase families that include JNKs,
cyclin CDKs, and MAP kinases (1-10).  For the subfamily of protein tyrosine kinases, the
molecular determinants of substrate recognition by the C-terminal Src kinase (Csk) have
been elucidated (11, 12).  For the Csk tyrosine kinase, six amino acids within the large lobe
of the kinase domain comprise a remote substrate-docking motif (12) that binds to a
complementary surface on the substrate (11).  This docking mechanism allows Csk to
recognize and phosphorylate its substrate in a specific manner.
The extent to which other families of non-receptor protein tyrosine kinases use
remote docking mechanisms to achieve substrate specificity is not known.  Of interest
here are the Tec family kinases; immunological enzymes that comprise the second
largest family of non-receptor tyrosine kinases.  The Tec family kinases include Itk,
Btk, Tec, Rlk and Bmx (13), and each contains a Src homology 3 (SH3) domain, Src
homology 2 (SH2) domain and the catalytic domain.
The current study focuses on Itk (Interleukin-2 tyrosine kinase), the Tec kinase that
participates in signaling processes following T cell receptor engagement by phosphorylating
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Tyr 783 of phospholipase Cg1 (PLCg1) (14-19).  Phosphorylation of PLCg1 on specific
tyrosine residues including Tyr 783 leads to activation of lipase activity (20).  In addition to
the PLCg1 substrate, Itk also undergoes autophosphorylation on Tyr 180 within its SH3
domain (18, 21).  The local amino acid sequences surrounding these two phosphorylation
sites are shown in Figure 1a and reveal little sequence similarity.  Moreover, the structural
context of these target tyrosines differ since Tyr 180 of Itk is embedded within the SH3
domain fold (Fig. 1b) while Tyr 783 of PLCg1 resides in a linker region between the
carboxy-terminal SH2 domain (SH2C) and SH3 domain of PLCg1 (Fig. 1c).  Thus, sequence
and structural differences between two known substrates of the Itk kinase raise questions
related to the mechanisms by which Itk recognizes its targets in a sufficiently specific manner
to maintain the fidelity of signal transduction.
In the present study, we find that the SH2 domain within each substrate serves a
docking role for recognition and phosphorylation by Itk.  In each of the substrates, the SH2
domain is remote from the site of phosphorylation and shuttles the substrate to the Itk kinase
domain by enhancing the affinity of the enzyme/substrate complex.  We also demonstrate
that efficient substrate phosphorylation by two other Tec kinases, Tec and Btk, is equally
dependent on SH2 docking indicating that this mechanism is conserved across the Tec
family.  Moreover, in contrast to the canonical, phosphotyrosine dependent binding behavior
of SH2 domains, we show that the SH2 domains of Itk substrates perform this docking
function in a phosphotyrosine-independent manner.
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Results
Efficient phosphorylation by the Tec kinases requires the SH2 domain of the substrate.
In vitro kinase assays using a panel of different substrates (Fig. 1b & c) were carried
out to assess the requirements for substrate phosphorylation by the Tec kinases.  Tyrosine
180 within the Itk SH3 domain is the site of Itk autophosphorylation (18) yet the isolated
SH3 domain does not serve as a substrate for full length Itk (Fig. 2a, lane 1).  In a similar
manner, the SH3 domains of Tec and Btk (containing the autophosphorylation sites Y187
and Y223, respectively) are not phosphorylated by the Tec and Btk kinases (Fig. 2b, lanes
1,2,5 & 6).  Finally, a fragment of PLCg1 that contains Tyr 783 and the adjacent SH3 domain
of PLCg1 is not phosphorylated by full length Itk (Fig. 2c, lanes 6-9).  Thus, efficient
phosphorylation of these Tec family substrates appears to require residues outside of the
target phosphorylation site.
To further test the determinants for substrate phosphorylation we created additional
Itk, Tec, Btk and PLCg1 substrate constructs and subjected them to phosphorylation by full
length Itk, Tec or Btk (Fig. 2a (lanes 2-4); 2b (lanes 3,4,7 & 8); 2c (lanes 2-5)).  In every
case, only substrates that contain both the site of phosphorylation (Y180 for Itk, Y187 for
Tec, Y223 for Btk, and Y783 for PLCg1) and the adjacent SH2 domain are phosphorylated
by the Tec kinases.  These data indicate that the SH2 domain adjacent to each
phosphorylation site is required for efficient recognition and phosphorylation by the full-
length Tec kinases.  To test whether substrate phosphorylation can be achieved by the
catalytic domain alone, the Itk SH3-SH2 substrate (Itk 32) was subjected to phosphorylation
by the isolated Itk kinase domain (Itk KD).   The Itk catalytic fragment leads to substrate
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phosphorylation (Fig. 2d) suggesting that the kinase domain of Itk is sufficient for
recognition of the SH2 domain-containing substrates.
The SH2 domains of Itk and PLCg1 interact with the Itk kinase domain in a phosphotyrosine-
independent manner.
Given the observation that the Itk kinase domain alone can phosphorylate substrate
and that each substrate requires the presence of the SH2 domain adjacent to the target
tyrosine residue, we investigated the extent to which the isolated SH2 domains of Itk and
PLCg1 interact directly with the Itk kinase domain.  Myc-tagged Itk SH2 domain, GST-
tagged PLCg1 C-terminal SH2 (PLCg1 SH2C) domain and FLAG-tagged Itk kinase domain
were purified and subjected to pull-down experiments.  The Itk kinase domain interacts
directly with both the Itk SH2 domain and the PLCg1 SH2C domain (Fig.3 a,b).  We tested
the nature of these interactions by mutating R265 in the Itk SH2 domain (22, 23) and R694
and R696 in PLCg1 SH2C domain (24) to abolish phosphotyrosine mediated interactions of
these SH2 domains.  Mutation of the conserved arginines in the SH2 domains of both
substrates has no discernable effect on substrate recognition and phosphorylation (Fig. 3c,d
& e).  To further probe phosphotyrosine requirements, we tested the effect of varying the
phosphorylation state of the Itk kinase domain on its interaction with the PLCg1 SH2C
domain. Itk kinase domain that is expressed in insect cells without co-expression of Lck does
not react with anti-pY antibody (Fig 3f (lane 1)) indicating an absence of phosphorylated
tyrosine within the Itk molecule.  In contrast, Itk kinase domain that is co-expressed with Lck
is expected to be phosphorylated on Tyr 511 in the activation loop.  Indeed, a
phosphotyrosine blot of the Itk kinase domain that is co-expressed with Lck reveals robust
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phophorylation (Fig. 3f (lane 2)).  Treatment with alkaline phosphatase effectively
dephosphorylates the Itk kinase domain as evidenced by the absence of reactivity to an anti-
phosphotyrosine antibody (Fig. 3f (lane 3)).  Using this panel of Itk kinase domain
preparations we found that PLCg1 SH2C domain binds to the Itk kinase domain regardless of
the phosphorylation status of the Itk kinase domain (Fig. 3g).  Thus, several pieces of
evidence point to a phosphotyrosine-independent interaction between the Itk kinase domain
and the SH2 domains of Itk and PLCg1 that mediates recognition and phosphorylation of
these physiological substrates.
Free SH2 domain competes with SH2 domain-containing substrate and reduces
phosphorylation of the substrate.
If the Itk SH2 domain and PLCg1 SH2C domain are indeed docking sites required for
the phosphorylation of Itk substrates, we expect that exogenous SH2 domain (either Itk SH2
or PLCg1 SH2C) should effectively compete for the binding site on the Itk kinase domain
and inhibit phosphorylation of the substrates. To address this, phosphorylation of Itk 32 and
PLCg1 SH2C-Y783- was monitored in the presence of increasing concentrations of either
free Itk SH2 domain or free PLCg1 SH2C domain (Fig. 4a,b).  For both substrates, the
corresponding free SH2 domain inhibits substrate phosphorylation (Fig. 4a,b) while two
different control SH2 domains (derived from PI3K and Grb2) do not inhibit the
phosphorylation of the substrates even at large molar excess (Fig. 4 a,b).  Inhibition by
exogenous SH2 domain extends to phosphorylation of the full-length protein.  In this case,
Tyr 180 within full length Itk is the substrate and autophosphorylation at this site is greatly
diminished upon addition of free Itk SH2 domain (Fig. 4c).
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Finally, we tested whether addition of free SH2 domain to the in vitro kinase assay
affects the phosphorylation of peptide B; a small model peptide substrate used previously to
measure Itk activity in vitro (25).  The levels of peptide B phosphorylation as indicated by
initial velocity measurements do not change significantly with increasing concentrations of
Itk SH2 domain (Fig. 4d) suggesting that SH2 binding to the kinase domain does not occur in
a manner that directly interferes with peptide B binding to the active site. Furthermore, this
result points to the absence of toxicity effects on Itk catalytic activity upon addition of free
SH2 domain providing further support for the direct competition with substrate shown in
Figure 4a-c.  Thus, a specific interaction between the SH2 domain of the Itk protein
substrates and the Itk kinase domain is required for efficient substrate phosphorylation and
appears to be localized outside of the catalytic cleft.
SH2 domain enhances substrate-binding affinity of a generic substrate.
The data described above predict that the SH2 domain within the substrates of the Tec
kinases serves a docking role and likely increases the affinity of substrates for the catalytic
domain.  To directly test this hypothesis, the PLCg1 SH2C domain was covalently linked to
the amino terminus of Peptide B (Fig. 5a).  To ensure that the desired tyrosine residue is the
only site within this construct that undergoes phosphorylation, we constructed a PLCg1
SH2C-Peptide B mutant that replaced the putative site of tyrosine phosphorylation with
serine (Fig. 5a).  This mutant did not incorporate phosphate indicating that the tyrosine
within the Peptide B sequence is the only site in the PLCg1 SH2C-Peptide B fusion that is
phosphorylated by Itk (Fig. 5b).
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Quantitative kinetic constants were compared for Peptide B alone and the PLCg1
SH2-Peptide B fusion (Fig. 5c-e).  Covalent attachment of the PLCg1 SH2C domain to
Peptide B increases substrate affinity as indicated by a reduced Km value; 5.64 mM for the
SH2-Peptide B fusion compared to 87 mM for Peptide B alone. The kcat value only changed
to a small extent suggesting that the SH2 domain primarily serves as a docking site to
facilitate substrate recognition and binding by the Itk kinase domain.  Thus, when linked to
the PLCg1 SH2C domain, Peptide B is a better substrate for Itk (exhibiting a 15-fold
increase in substrate affinity) providing further support for the finding that Itk catalytic
efficiency and selectively depends upon docking interactions with the substrate SH2
domain.
Discussion
We have demonstrated a previously unrecognized docking role for the SH2 domain
within the substrates of the Tec kinases that facilitates phosphorylation at a remote tyrosine.
Many kinase sequences contain SH2 domains and these binding modules are known to affect
the association of the parent kinase molecule within a signaling complex (26).  Additionally,
processive phosphorylation mediated by SH2/phosphotyrosine interactions has been
described previously (27-29).  In those examples, a tyrosine kinase creates a binding site on
the substrate for its own internal SH2 domain; the ensuing SH2-substrate interaction leads to
efficient phosphorylation at additional sites on the substrate.  In contrast to the role of the
SH2 domain in the processive phosphorylation mechanism, the results presented here suggest
that SH2 domains within the substrates of the Tec kinases harbor a recognition motif that is
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required for efficient and selective phosphorylation of the target tyrosine.  For example, the
direct substrate of Itk in T cells, PLCg1, harbors an SH2 domain (SH2C) that binds directly
to the Itk kinase domain allowing the downstream PLCg1 tyrosine (Tyr 783) to be efficiently
phosphorylated by Itk.  As well, autophosphorylation of Try 180 in the Itk SH3 domain
depends on Itk SH2 mediated interactions with the Itk kinase domain.  This mode of
substrate recognition is evident within the full-length enzyme as addition of competing
exogenous Itk SH2 domain to full length Itk completely eliminates Itk autophosphorylation
(see Fig. 4c).  To our knowledge, this direct kinase domain - SH2 interaction is a novel mode
of substrate recognition that provides significant insight into how the Tec kinases achieve
fidelity in their interactions with appropriate substrates and avoid deleterious ‘cross-talk’
with other substrates.
Our findings are consistent with a previous study of autophosphorylation within the
Tec family kinases (21) that provided a hint into the docking role of the SH2 domain.  Smith
and co-workers qualitatively showed that the SH3-SH2 fragments of Btk and Itk are both
phosphorylated preferentially to the isolated Btk SH3 domain by the Btk kinase (21).  The
authors speculated that the SH3-SH2 substrate may have additional interactions with the
kinase or that the site of phosphorylation in the SH3 domain becomes more accessible in the
larger SH3-SH2 substrate.  They also left open the possibility that there are new
phosphorylation sites on the larger SH3-SH2 substrate but report that the SH2 domain of Btk
is not a substrate for Btk.  The data we present strongly supports a model where the SH2
domain serves a direct docking role that is a significant determinant of substrate specificity
for the Tec kinases.  It is especially interesting to note that Smith and co-workers report
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phosphorylation levels for the SH3-SH2 fragment that are 5- to 8-fold higher than the
isolated SH3 domain (21).  This is in excellent agreement with kinetic data shown in Figure 5
that indicate that Peptide B is a better substrate by 7-fold (kcat/Km) when tethered to the SH2
domain of PLCg1. Finally, our use of phosphotyrosine specific antibodies and mutation of
the target tyrosine supports the notion that additional phosphorylation sites in the SH2
domain containing substrates are not leading to the observed increase in substrate
phosphorylation (21).
The phosphotyrosine-independent nature of the binding event between Itk kinase
domain and SH2 domains, highlights alternative means by which SH2 domains can engage
their targets.  To date, targeting the conserved arginines in the phosphotyrosine binding
pocket of the SH2 domain has become the traditional ‘loss-of-function’ mutation for this
binding module.  A full appreciation of phosphotyrosine-independent SH2 binding will lead
to revised models of signaling complexes.  For PLCg1 signaling in particular, traditional
mutagenic approaches targeting the phosphotyrosine binding site of the SH2C domain have
previously led to conclusions that this portion of PLCg1 is dispensable for PLCg1 recruitment
and phosphorylation (30, 31).  More recently, the extended experimental approach of
Samelson and co-workers showed that all three SH domains including SH2C are required for
phosphorylation of PLCg1 in T cells (32) yet these studies still relied on the mutation of
arginine in the phosphotyrosine binding pocket of the SH2C domain.  Certainly, the
phosphotyrosine-independent docking role for the PLCg1 SH2C domain would have been
missed by standard ‘loss-of-function’ mutations in the SH2 domain.
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To fully characterize this novel, SH2 dependent substrate recognition mechanism, the
interaction sites on both the Itk kinase domain and the substrate SH2 domains must be
mapped at the molecular level.  In addition to providing insight into the PLCg1 activation
mechanism, the precise arrangement of the Itk SH2 domain within the full-length Itk enzyme
is of particular interest.  In other tyrosine kinases, the non-catalytic SH2 domain plays a
defined role in regulating kinase activity by forming direct intramolecular contacts to the
small lobe of the kinase domain (33, 34).  For Itk we have also found that the SH2 domain
positively contributes to the regulation of catalytic activity (Joseph and Andreotti,
unpublished results).  Thus, the emerging bifunctional nature of the Itk SH2 domain (as
substrate recognition module and regulatory domain) raises interesting questions related to
how the Itk SH2 domain orchestrates its various roles during enzymatic catalysis.  Does this
SH2 domain interact with its neighboring kinase domain in a single mode that achieves both
regulation of kinase activity and substrate recognition of the autophosphorylation site or does
the SH2 domain shift between multiple interaction sites on the kinase domain to achieve
these functions?   With molecular level details still forthcoming, it is nevertheless clear that
the data we present here point to a specific SH2 domain mediated docking mechanism by
which the Tec kinases recognize and phosphorylate their substrates.  One extension of this
result is that screening for interactions between the Tec kinase domains and unrelated SH2
domains may provide leads to identify additional substrates for this important family of
tyrosine kinases.  In addition, we have shown that Itk substrates can be displaced from the
active site by addition of exogenous SH2 domain.  This result promises an exciting strategy
to attenuate Itk mediated signaling that may have significant selectivity advantages since it
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would not require the development of molecules that discriminate between very similar
kinase active sites.
Materials and Methods
Baculoviral and bacterial constructs - Full-length Itk, Btk and Tec and the Itk kinase
domain fragments were PCR amplified using a reverse primer that encoded a FLAG epitope
tag.  The PCR products were cloned into the pENTR/D-TOPO vector (Invitrogen) by TOPO
cloning.  All of the PLCg1, Itk, Btk and Tec fragments that do not contain kinase domain
were subcloned into the pGEX-2T expression vector (GE Healthcare) for production and
purification from bacteria as described previously (35). The N-terminal Phosphatidylinositol
3-Kinase (p85a) SH2 domain (PI3K SH2) and Grb2 SH2 domain were cloned into pGEX-
5X-1 by PCR.  The pGEX-2T PLCg1 C-terminal SH2 domain-PeptideB fusion was created
by PCR and included an N-terminal biotinylation sequence.  For this construct and the
pGEX-2T PLCg1 SH2C-PeptideB(YS) mutant, Tyr 771 was mutated to Phe to avoid
phosphorylation at this site during analysis of the kinetics and Tyr 775 has been deleted by
replacement with the Peptide B sequence (36).  Biotinylated protein was produced in BL21
cells by co-expressing Biotin ligase.  The biotinylated protein was purified by affinity
purification using an Avidin resin (Pierce).  For the Itk substrate constructs that include both
the SH3 and SH2 domain (Itk32 and Itk32(Y180F)) we also introduced two point mutants
(W208K and I282A) to eliminate complications that may arise from dimerization of the
substrate as reported previously (35).  The wild type Itk SH3-SH2 construct is
phosphorylated by Itk to the same extent as the double mutant (data not shown). All
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mutations were made using the site directed mutagenesis kit (Stratagene). All constructs were
verified by sequencing at the Iowa State University DNA synthesis and sequencing facility.
Baculovirus production - The pENTR vectors with various inserts were recombined
in vitro with BaculoDirect C-Term Linear DNA (Invitrogen) using LR Clonase II enzyme
(Invitrogen). The DNA was then transfected into Sf9 cells using Effectene (Qiagen). Three
rounds of viral selection and amplifications were carried out. For protein production, the cells
were infected with a 1:1 ratio of Itk (or Btk or Tec): Lck baculovirus unless otherwise
indicated. The cells were harvested 72 hrs post-infection, rinsed once with phosphate
buffered saline (PBS) and stored at –80°C.  Following purification each Itk enzyme construct
was assessed for Tyr 511 phosphorylation using a Btk pY551 specific antibody.  This step
ensured that co-expression with Lck produced appropriately activated Itk (18).
Pull-Down Assays - Purified 0.5 mM FLAG-tagged Itk kinase domain (Itk KD)
immobilized on an anti-FLAG-resin was incubated with 1mM purified Myc-tagged Itk SH2
(Itk SH2-myc) domain in RIPA buffer (50mM Tris pH7.4, 150mM NaCl, 1mM PMSF, 1%
NP40, 1mM EDTA, 1mM NaF) at 4°C overnight. The samples were washed, boiled, resolved
on an SDS-PAGE gel, transferred to PVDF membrane and western blotted with an anti-Myc
antibody (Invitrogen). For PLCg1 pull downs 0.22 mM FLAG-tagged Itk kinase domain (Itk
KD) was incubated with 3.8 mM of purified GST or 3.8 mM GST-PLCg1 SH2C immobilized
on glutathione beads. The samples were treated as before and western blotted using an anti-
FLAG antibody. Unphosphorylated FLAG-tagged Itk Kinase domain (Itk KD) was prepared
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by treating 13.6 mM Itk KD with 1 unit/mL of Alkaline phosphatase (New England Biolab)
for 1hr at 37oC.
Protein purification - Purification of baculovirus produced protein was carried as
previously described (25). Cell pellets were resuspended in lysis buffer (50mM Tris pH 8.0,
500mM NaCl, 2mM EDTA, 1mM PMSF) and lysed by dounce homogenization. The
homogenate was spun at 16K for 1hr at 4°C. Glycerol was added to the supernatant to a final
volume of 10%, and then incubated with anti-FLAG M2 affinity resin (Sigma) for 5hrs at
4°C. The resin was rinsed five times in wash buffer (50mM Tris pH 8.0, 500mM NaCl, 1mM
PMSF, 10% glycerol), and if necessary for kinase assays, the protein was eluted in elution
buffer (wash buffer with 200mg/ml FLAG peptide) and stored at -80°C. The purified protein
was quantified by measuring absorbance at 280nm.  All proteins were greater than 95% pure
by Coomassie staining.  We note that the Btk SH3 domain runs higher than the actual
molecular weight and the closely related Tec SH3 domain (Fig. 2b). The molecular weight of
both Btk SH3 domain and Tec SH3 domain were confirmed by mass spectrometry (data not
shown).  Additionally, identical preparations of Itk mutant enzymes that are kinase inactive
(K390R) do not show any activity toward any substrate (data not shown).
Kinase assays and Western Blotting - Itk Full-length (FL), linker kinase domain (Itk
LKD), kinase domain (Itk KD), full-length Btk or full-length Tec were incubated with the
indicated substrates in an in vitro kinase assay buffer (50mM Hepes pH 7.0, 10mM MgCl2,
1mM DTT, 1mg/ml BSA, 1mM Pefabloc and 200mM ATP) for one hour at RT.  The samples
were boiled, separated by SDS-PAGE and transferred onto a PVDF membrane. The
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membranes were then blotted with either phosphotyrosine specific antibodies (anti-pY783 for
PLCg1 or pY223 Btk antibody used to detect pY180 in Itk, pY187 in Tec and pY223 in Btk
(18)), an anti-phosphotyrosine antibody (4G10 from Upstate), or an anti-FLAG antibody
(Sigma) and developed by standard chemiluminescence (Pierce) methods. Quantitative
kinase assays (2 5 ): K m determinations for Peptide B [(Aminohexanoyl biotin-
EQEDEPEGIYGVLF-NH2) (Anaspec Inc.)] and the biotinylated PLCg1 SH2C-Peptide B
fusion were carried out by incubating purified Itk LKD enzyme in reaction buffer (50 mM
Hepes pH 7.0, 10 mM MgCl2, 1 mM DTT, 1 mg/ml BSA, 1 mM Pefabloc SC (4-(2-
aminoethyl)-benzenesulfonyl-fluoride) and 200 mM ATP) and 5 mCi [32P] ATP (GE
Healthcare) at room temperature. Peptide B concentration was varied between 0-400 mM and
PLCg1 SH2C-Peptide B fusion concentration was varied between 0-80 mM.  The enzyme
concentration used for kinetic analysis was 0.9 mM. Each assay was done in duplicate. The
data obtained was fitted onto the Michealis-Menten equation using GraphFit 5 software, and
the kinetic parameters were obtained.
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Figure Captions
Figure 1. Domain structures of Tec kinases and PLCg1.  (a) Sequences surrounding Y783
in PLCg1 and Y180 in Itk SH3.  Tyrosine residues that are phosphorylated by Itk are boxed.
(b) Domain structure of Itk and specific Itk constructs used in this study.  The
autophosphorylation site of Itk, Y180 within the SH3 domain, is indicated. The domain
structures of Tec and Btk are the same as Itk and the Tec and Btk domain fragments used in
this study follow the same nomenclature (Btk SH3, Btk 32 (each contain Y223) Tec SH3 and
Tec 32 (each contain Y187)). (c) The domain structure of PLCg1 contains a PH domain, EF
hand motif, the catalytic domain (comprising the X and Y domains), two SH2 domains
(SH2N and SH2C for amino- and carboxy terminal respectively), SH3 domain, a split PH
domain indicated by (P and H) and the C2 domain.  The PLCg1 fragments used in this study
are shown and substrate fragments each include Y783, the target of Itk kinase activity.
Figure 2. Tec mediated phosphorylation requires the SH2 domain adjacent to the target
tyrosine. (a) Only Itk fragments that contain the SH2 domain and Y180 are phosphorylated
by Itk.  Ten mM each of Itk SH3, Itk SH3-Linker (Itk 3Linker), Itk SH3-SH2 (Itk 32) or Itk
SH3-SH2 with a phenylalanine in place of the Y180 phosphorylation site (Itk 32(Y180F))
were incubated with 250 nM FLAG-tagged Itk full-length (FLItk) enzyme in an in vitro
kinase assay.  Lanes 5-8, are no enzyme controls.  Phosphorylation on Y180 in the SH3
domain is detected with an anti-pY223 Btk antibody (denoted anti-pY180 throughout).
Throughout, Coomassie or Ponceau S stain of the gel, anti-FLAG blots and anti Itk blot
(bottom panels) show protein levels. For panels a-c, Coommassie stain of the SH3 domain
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fragments is consistently less efficient than the larger constructs but protein amounts across
these experiments are uniform based on measured absorbances.  Astericks next to
Commassie stained gel indicate position of Itk 32, Itk 3Linker and Itk SH3.  (b)
Phosphorylation of the Tec and Btk substrates was carried out in a manner similar to that
shown in (a) for Itk.  Btk SH3 (5 and 10 mM respectively in lane 1-2) or Btk SH3-SH2 (Btk
32) (5 and 10 mM respectively in lanes 3,4) were incubated with 100 nM FLAG-tagged Btk
full-length enzyme in an in vitro kinase assay.  Tec SH3 (5 and 10 mM respectively in lanes
5,6) or Tec SH3-SH2 (Tec 32) (5 and 10 mM respectively in lanes 7,8) were incubated with
100 nM FLAG-tagged Tec full-length enzyme in an in vitro kinase assay.  Lanes 9-12 are the
no enzyme controls at substrate concentrations of 10 mM.  Phosphorylation on Y223 in the
Btk SH3 and Y187 in Tec SH3 domain are detected with an anti-pY223 Btk antibody.
Astericks next to Commassie stained gel indicate position of Tec 32, Btk 32, Btk SH3 and
Tec SH3. (c) Efficient phosphorylation of PLCg1 Y783 by Itk occurs only when the adjacent
PLCg1 SH2 domain is present.  Lane 1 is enzyme alone control.  Varying concentrations (1,
3, 5 and 10 mM in lanes 2-5, respectively) of the fragment of PLCg1 that contains both the
SH2C domain and the following 33 amino acids (PLCg1 SH2C-Y783-) or the PLCg1
fragment that contains the 33 residue linker followed by SH3 domain (PLCg1 -Y783-SH3, 1,
3, 5 and 10 mM in lanes 6-9, respectively) were subjected to in vitro phosphorylation by 1.2
mM FLAG-tagged Itk full-length enzyme.  Phosphorylation on Y783 in the PLCg1 constructs
is detected using an anti-pY783 PLCg1 antibody. (d) 2 mM purified FLAG-tagged Itk kinase
domain alone (Itk KD) was incubated with 1mM (lane 2) or 10mM (lane 3) Itk 32 domain in
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an in vitro kinase reaction as before.  Lane 1 is 10 mM Itk 32 domain alone with no enzyme.
All data shown are representative of at least three independent experiments.
Figure 3. Itk kinase domain interacts directly with PLCg1 and Itk SH2 domains in a
phosphotyrosine independent manner. (a) Empty anti-FLAG resin (lane 1) or purified
FLAG-tagged Itk kinase domain (Itk KD) immobilized on an anti-FLAG-resin (lanes 2 and
3) were incubated with purified myc-tagged control protein (lane 2) or myc-tagged Itk SH2
domain (lanes 1 and 3) in a pull-down assay. Blotting with an anti-Myc antibody reveals a
direct interaction between purified Itk kinase domain and the purified Itk SH2 domain (lane
3). (b) Purified FLAG-tagged Itk KD (lane 1) was incubated with GST (lane 2) or GST-
PLCg1 C-terminal SH2 domain (GST-PLCg1 SH2C) (lane 3) each immobilized on
glutathione beads in a pull-down assay.  Anti-FLAG antibody reveals a direct interaction
between the Itk kinase domain and the C-terminal SH2 domain of PLCg1. (c) Interaction
between the Itk kinase domain and Itk SH2 domain leading to phosphorylation of substrate
does not involve the phosphotyrosine binding pocket of the SH2 domain. One mM Itk 32
(lanes 1 and 3) or Itk 32 (R265K) (lanes 2 and 4), were incubated with 250 nM FLAG-tagged
full-length Itk in an in vitro kinase assay.  Lanes 1 and 2 are no enzyme control. Antibody
specific for Itk pY180 shows that the conserved arginine in the phosphotyrosine binding
pocket of the SH2 domain is not required. (d-e) Effective phosphorylation of PLCg1 Y783 by
the Itk kinase domain does not require the phosphotyrosine binding pocket of the PLCg1 SH2
domain. One, 3, 5 and 10 mM PLCg1 SH2C-Y783- (d) or PLCg1 SH2C(R964A,R696A)-
Y783- (e), were subjected to phosphorylation by 1.2 mM full-length FLAG-tagged Itk. Lanes
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5 and 6 (containing 1 and 10 mM substrate, respectively) are no enzyme controls. Coomassie
stain of the gels and anti-FLAG blots (bottom panels) show protein levels. (f & g) Interaction
between the SH2 domain and Itk kinase domain is independent of the phosphorylation status
of the kinase domain. (f) FLAG-tagged Itk KD that is expressed alone (lane 1) does not react
with a general phosphotyrosine (4G10) antibody while Itk co-expressed with Lck (lane 2) is
phosphorylated.  Itk KD that is co-expressed with Lck but also pretreated with alkaline
phosphatase is not phosphorylated (lane 3).  (g) Purified FLAG-tagged Itk KD that is either
expressed alone (lanes 1 & 2), co-expressed with Lck (lanes 3 & 4) or treated with alkaline
phosphatase (lanes 5 & 6) were incubated with immobilized GST (lanes 1, 3 and 5) or
immobilized GST-PLCg1 SH2C, (lanes 2, 4 and 6) in a pull-down assay. An anti-FLAG blot
reveals binding of Itk KD to GST-PLCg1 SH2C and not to GST alone. Ponceau S staining of
the membrane (bottom panel) shows the protein levels.  All data shown are representative of
at least three independent experiments.
Figure 4. The presence of isolated SH2 domain diminishes phosphorylation of Itk Y180
or PLCg1 Y783. Substrate used in each experiment is indicated above each set of blots. (a)
(left) Itk 32 substrate was incubated with Itk full-length enzyme as before (lane 1), or with
Itk 32 domain:free Itk SH2 domain in ratios of 1:10, 1:25 or 1:50 (lanes 2-4, respectively) or
equivalent ratios of PI3K N-terminal SH2 domain (lanes 5-7) and subjected to an in vitro
kinase assay.  Anti-pY180 antibody shows that free Itk SH2 domain competes with the Itk 32
substrate while the SH2 domain from PI3K does not.  Coomassie stain and an anti-FLAG
blot (bottom panels) show protein levels. (right) The PLCg1 SH2 domain competes with the
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PLCg1 substrate in a similar manner.  Lane 1 contains only Itk enzyme and PLCg1 SH2C-
Y783- substrate without additional free SH2 domain.  Ratios of free SH2 domain to substrate
are 1:5, 1:10 or 1:50 in lanes 2-4, respectively and equivalent ratios of PI3K SH2 domain are
used in lanes 5-7.  Coomassie stain of the gel and an anti-Itk blot (bottom panels) show
protein levels.  (b) Same experiment as shown in (a) using the Grb2 SH2 domain as a control.
(left) Itk 32 substrate was incubated with Itk full-length enzyme (lane 1), or with Itk 32
domain:free Itk SH2 domain in ratios of 1:10 and 1:25 (lanes 2 & 3) or equivalent ratios of
Grb2 SH2 domain (lanes 4 & 5) and subjected to an in vitro kinase assay. (right) Identical
experiment following PLCg1 substrate phosphorylation in the presence of the PLCg1 and
Grb2 SH2 domains.  Lane 1 is PLCg1 substrate alone; lanes 2 & 3 are PLCg1
substrate:PLCg1 SH2 domain in a 1:10 and 1:25 ratio, respectively and lanes 4 & 5 are
identical ratios of PLCg1 substrate:Grb2 SH2 domain. (c) The Itk SH2 domain competes
with autophosphorylation of Y180 within full length Itk.  For lanes 2-4, the amount of free
SH2 domain is the same as used in panel (a), lanes 2-4.  No exogenous SH2 domain has been
added in lane 1 and full length Itk is both the enzyme and the substrate. Coomassie stain and
an anti-FLAG blot (bottom panels) show protein levels. (d) Free Itk SH2 domain does not
compete with phosphorylation of a peptide substrate.  Initial velocities are shown for
phosphorylation of peptide B (sequence shown in Fig. 5a) by full length Itk in the absence
(column 1) and presence (column 2 and 3) of Itk SH2 domain.  The amount of SH2 domain
used here is the same as that used in lanes 3 and 4 in (c).
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Figure 5.  PLCg1 C-terminal SH2 domain can mediate docking of Peptide B into the
kinase active site of Itk.  (a) Construction of a PLCg1 SH2C-Peptide B fusion protein was
based on alignment of Y783 within the PLCg1 linker and the Tyr of Peptide B.  The 14
amino acids of Peptide B were used to replace the last 16 amino acids of PLCg1 SH2C-
Y783-.  The Tyr that is phosphorylated in each substrate is boxed.  A mutant construct is also
shown that contains serine in place of the tyrosine of peptide B.  This site was mutated to
serine instead of phenylalanine due to solubility problems associated with the Tyr to Phe
mutation.  (b) FLAG-tagged Itk LKD enzyme (1 mM) was incubated with 20 mM of the
PLCg1 SH2C-Peptide B fusion protein (lane 4) or 20 mM of the PLCg1 SH2C-Peptide B(YS)
mutant protein (lane 5) in an in vitro kinase assay.  Lanes 1-3 are Itk enzyme alone, PLCg1
SH2C-Peptide B substrate alone and PLCg1 SH2C-Peptide B(YS) substrate alone,
respectively, that have each been subjected to the same in vitro kinase assay conditions. (c &
d) FLAG-tagged Itk LKD enzyme was incubated with increasing amounts of biotinylated
PLCg1 SH2C-Peptide B (c) or biotinylated Peptide B alone (d) in an in vitro kinase assay. (e)
Kinetic parameters describing phosphorylation of Peptide B and the PLCg1 SH2C-Peptide B
fusion protein by Itk.  Data shown are the average of two independent experiments.
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CHAPTER 3. PHOSPHOLIPASE Cg1 PHOSPHORYLATION BY ITK
 IS MEDIATED BY A NON-CLASSICAL SH2 SURFACE
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The manner in which protein kinases achieve substrate specificity remains elusive for most
enzyme/substrate pairs.  To date, substrate docking mechanisms have been described for
many serine/threonine kinases but our understanding of substrate recognition within the
tyrosine kinase subfamily has lagged.  This has led to the notion that the tyrosine kinases
accomplish specific phosphorylation of their targets through the action of modular non-
catalytic domains rather than direct docking of substrate onto the kinase domain.  Contrary to
this model, we show that the second largest family of tyrosine kinases, the Tec kinases,
recognize their substrates via a direct docking interaction between kinase domain and
substrate.  We define the precise docking surface on PLCg1, the physiological substrate of
one of the Tec kinases, Itk.  The binding surface on PLCg1 that mediates recognition by Itk
highlights a non-classical binding activity of the well-studied Src homology 2 (SH2) domain




Protein kinases control numerous cellular signaling networks by phosphorylating target
amino acid side chains in a stringently specific manner.  Based on results of combinatorial
peptide library screens and structures of kinase/peptide substrate complexes, the view has
emerged that the active sites of most kinases can tolerate different sequences and are
therefore not stringently specific for short peptide sequences 1,2.  Stringent specificity is
however a requirement of cellular signaling cascades and so these enzymes must have
mechanisms that control fidelity.
Two modes of achieving strict target specificity have been described for the protein kinases,
one invoking a role for the modular recognition domains (such as SH3 and SH2) that are
often found adjacent to the catalytic domain.  For the SH2 domain in particular, processive
phosphorylation mediated by SH2/phosphotyrosine interactions has been well described 3-5.
In these examples, a tyrosine kinase creates a binding site on the substrate for its own internal
SH2 domain; the ensuing SH2-substrate interaction leads to efficient phosphorylation at
additional sites on the substrate.  Alternatively, specific docking interactions between a
kinase domain itself and a recognition element within the substrate have been described 6.
Docking-based substrate interactions typically involve recognition of a substrate motif by a
region of the catalytic domain that lies outside of the active site.  Substrate docking has been
described to date almost exclusively for the serine/threonine kinases; enzymes that often lack
modular binding domains outside of the kinase domain 7.
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Substrate docking interactions have not to date been extensively described for the tyrosine
kinase family.  These enzymes often contain the modular binding domains thought to
mediate localization of the kinase domain to substrates and thus, in general, emerging notions
of substrate specificity for the serine/threonine versus the tyrosine kinases have emphasized
specific docking interactions for the former and canonical SH3 and SH2 mediated
interactions controlling specificity for the latter 2,6.  The C-terminal Src kinase, Csk, is the
exception to these generalizations since it is a tyrosine kinase, contains an SH3 and SH2
domain, but has been shown to present a binding groove on its kinase domain that serves a
direct substrate docking role 8,9.  Thus, the extent to which docking is a general mechanism
exploited by both the tyrosine and serine/threonine kinases to achieve substrate specificity
has yet to be determined.
In support of direct substrate docking as a general phenomenon among the broad class of
protein kinases, we describe a specific docking interaction between the Tec family tyrosine
kinases and their physiological substrates 10.  Like Csk, the Tec kinases (Itk, Btk, Rlk, Bmx
and Tec) all contain an SH3 and SH2 domain in addition to the catalytic kinase domain.
While the non-catalytic binding domains most certainly localize the Tec kinases
appropriately during signaling 11,12, we have shown that the kinase domain itself of each of
the Tec kinases directly contacts its cognate substrate in a manner that confers significant
specificity 10.  For example, the Itk kinase domain contacts a recognition element presented
by its substrate, phospholipase Cg1 (PLCg1), that is remote from the site of phosphorylation
(Y783 within PLCg1).
67
We now identify the precise docking determinants within PLCg1 that are required for
specific phosphorylation by the Itk kinase and show that the recognition element is present in
the full length PLCg1 substrate.  The docking element resides with the second SH2 domain
of PLCg1 (SH2C) and does not coincide with the classical phosphotyrosine ligand binding
surface of the SH2 domain.  The results therefore define a new SH2 surface that mediates
protein-protein interactions and provide evidence that, in addition to the serine/threonine
kinases, the general tyrosine kinase family also exploits substrate docking interactions to
achieve target specificity.
Results
In activated T cells, Itk mediated phosphorylation of PLCg1 leads to activation of lipase
activity and subsequent hydrolysis of phosphatidylinositol (4,5)bisphosphate (PIP2) to
inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG).  IP3 and DAG in turn stimulate
the release of calcium ions from the endoplasmic reticulum and activate Protein Kinase C,
respectively (for a review see 13).  Thus activation of PLCg1 by Itk is a critical component of
T cell activation and differentiation 14 yet the molecular mechanisms by which Itk
specifically targets PLCg1 have not been described.  PLCg1 contains a PH domain, EF hand
motif, the catalytic domain (comprising the X and Y domains), two SH2 domains (SH2N and
SH2C for amino- and carboxy-terminal respectively), a SH3 domain, a split PH domain
indicated by (P and H) and the C2 domain (Fig. 1a).  The carboxy-terminal SH2 domain
(SH2C) of PLCg1 spans residues 659 to 756 within full length PLCg1 and the site of tyrosine
phosphorylation by Itk resides at position 783 15-17.
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The PLCg1 SH2C domain is required for efficient phosphorylation of Y783 (Fig. 1b; lane 1)
and fragments of PLCg1 that do not contain both SH2C and Y783 are not efficiently
phosphorylated by Itk 10.  Moreover, PLCg1 substrate fragments that do contain both SH2C
and Y783 (spanning 659 to 789; hereafter referred to as PLCg1 SH2C-linker) can be titrated
away by addition of free PLCg1 SH2C domain (residues 659 to 756) (Fig. 1b, lanes 2 & 3).
Competition by free SH2C domain is specific as the SH2 domains from Grb2 (Fig. 1b, lanes
4 & 5) and PI3K (not shown) have no effect on Itk mediated phosphorylation of Y783 in
PLCg1.  Thus, the PLCg1 SH2 domain presents a recognition motif to the Itk kinase domain
that promotes phosphorylation of the remote Y783 (Fig. 1c).  Our previous work also clearly
demonstrated that the PLCg1 SH2C domain mediates docking to the Itk kinase domain in a
non-classical manner (phosphotyrosine-independent) and that SH2C contacts the Itk kinase
domain in a manner that does not occlude the kinase active site (Fig. 1c) 10.  Finally, it should
be understood that this mechanism of substrate recognition is distinct from that of processive
phosphorylation.  The SH2 domain of interest resides within the substrate and the Itk kinase
domain itself is responsible for substrate recognition rather than an SH2 domain within the
enzyme 10.  Thus, despite the presence of the modular SH3 and SH2 domains within Itk,
substrate recognition occurs via a direct docking interaction between the kinase domain of Itk
and an SH2 domain in the substrate.
To identify the precise SH2 docking surface responsible for substrate recognition by the Itk
kinase domain, we compared the primary sequences of the PLCg1 SH2C domain derived
from several species with the primary sequences of two SH2 domains that do not compete
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with Itk mediated substrate phosphorylation (PI3K and Grb2).  Surface exposed residues that
are conserved across the PLCg1 SH2 domains from different species but differ in either PI3K
or Grb2 (or both) were targeted for mutation.  A total of 24 PLCg1 SH2C candidate residues
(Fig. 1d) were identified as potential substrate docking site residues.  We expect that
mutation of the docking motif that mediates the direct Itk/PLCg1 substrate interaction will
result in loss of substrate phosphorylation.
Using the PLCg1 SH2C-linker substrate shown in Figure 1b & c, each of the 24 SH2C
residues indicated in Figure 1d were mutated to alanine.  Wild type SH2C-linker substrate
and the resulting panel of mutant substrates were subjected to an in vitro phosphorylation
assay using full-length Itk enzyme (Fig. 2a).  Phosphorylation levels for each substrate were
assessed by western blot using the anti-pY783 antibody.  As shown in Figure 2a, mutation of
E709, K711, R748, K749, K751, and R753 to alanine (lanes 19-27) either completely
abolishes or significantly diminishes Itk mediated phosphorylation of Y783 in the PLCg1
SH2C-linker substrate.  These data provide evidence that these SH2 domain residues are
required for phosphorylation of the remote Y783 site.  Mutation of the other residues in the
SH2C domain had little or no effect on the phosphorylation efficiency of the PLCg1 SH2C-
linker substrate (Figure 2a; lanes 4-18 & 28-39).  Substrate phosphorylation levels that are
equal to wild type substrate in this functional assay indicate that the mutated residues do not
contribute to the docking interaction between PLCg1 SH2C domain and Itk kinase domain.
Before considering the structural implications of mutational analysis, we made use of circular
dichroism (CD) spectroscopy to ensure that the individual mutations do not cause large
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structural changes to the SH2C-linker substrate that could account for the absence of
phosphorylation on Y783 (Fig. 2b).  The CD spectra acquired for wild type and each of the
purified mutant substrates indicate that none of the substrate fragments were significantly
altered in secondary structure as a result of surface mutation.  Thus, the results of the
mutational analysis shown in Figure 2a indicate a set of surface residues on the PLCg1 SH2C
domain that mediate formation of an enzyme/substrate docking complex between Itk and
PLCg1 that is required for Y783 phosphorylation.
Mapping the mutational results from Figure 2a onto the structure of the PLCg1 SH2C domain
reveals a binding surface that consists largely of basic amino acids located apart from the
canonical phosphotyrosine binding site on the SH2 domain (Fig. 3a & b).  K711 and E709
reside on the CD loop of the SH2C domain and R748, K749, K751 and R753 are located
within the C-terminus of the domain.  Residues for which mutation to alanine has no
detectable effect on Y783 phosphorylation in the Itk phosphorylation assay (Fig. 2a) lie
outside of this newly identified binding site and are depicted in orange in Figure 3a.
Visualizing the docking site on the structure of the PLCg1 SH2C domain bound to a
phosphopeptide ligand (Fig. 3b) clearly shows why mutations in the pY pocket that disrupt
classical phosphotyrosine binding of the SH2 domain have no effect on the substrate docking
activity 10.  The PLCg1 SH2C domain contains separate and non-overlapping surfaces that
control phospholigand binding and substrate docking.
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We next examined the extent to which the Itk/PLCg1 docking interaction mediates
phosphorylation of Y783 in the full-length PLCg1 substrate instead of the short SH2C-linker
substrate fragment used thus far (Figs. 1 & 2).  Given the previous observation that free
PLCg1 SH2C domain can compete with phosphorylation of Y783 by Itk (Fig. 1b), we carried
out the same experiment using full length PLCg1 as substrate.  In a manner completely
analogous to the earlier fragment study, we find that the isolated PLCg1 SH2C domain
competes effectively with Itk mediated phosphorylation of Y783 within full length PLCg1
(Fig. 4a; lanes 1-3).  In analogy to the earlier experiment using the PLCg1 substrate fragment
(Fig. 1b), the same concentration of Grb2 SH2 domain is significantly less effective in
competing with docking of full length PLCg1 (Fig. 4a; lanes 8 & 9).  We also generated two
separate PLCg1 SH2C domains carrying point mutations in the identified docking site
(K749A/R753A and R748A/K751A).  Like the Grb2 SH2 domain, these mutated PLCg1
SH2C domains do not compete with full-length PLCg1 phosphorylation by Itk (Fig. 4a; lanes
4-7) providing further evidence that the cluster of basic residues identified on the surface of
the PLCg1 SH2C domain (Figs. 2a & 3a) mediate substrate docking onto Itk.
To complement the competition assays shown in Figure 4a, we next directly targeted the
SH2C docking surface within full length PLCg1.  The same mutations in the SH2C domain
(K749A/R753A and R748A/K751A) were incorporated into full length PLCg1 and then wild
type PLCg1 and each mutant was then subjected to phosphorylation by the full length Itk
enzyme (Fig. 4b).  Both sets of mutations diminish Y783 phosphorylation by Itk; the level of
phosphorylated Y783 in wild type full length PLCg1 is significantly higher than either
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mutant.  Comparing the two mutants, it is also interesting to note that the K749A/R753A
mutation diminishes the pY783 level to a greater extent than the R748A/K751A mutant
suggesting that these two residues might play a more significant role in binding to Itk.  This
is consistent with the differences between these two mutants in the fragment study described
in Figure 2a.  These data therefore provide evidence that a region of the PLCg1 SH2C
domain that is located outside of the canonical phosphotyrosine binding site and is remote
from the site of tyrosine phosphorylation, Y783, mediates specific phosphorylation of PLCg1
by the Itk kinase.  This work ascribes a new function to the ubiquitous SH2 domain; substrate
presentation of a specificity conferring recognition element to its cognate tyrosine kinase.
Discussion
The substrate docking mechanism that we have described for the Tec family tyrosine kinase,
Itk, complements the elegant work describing a similar substrate recognition mechanism for
the Csk/Src enzyme/substrate pair.  These examples are beginning to suggest that, like their
serine/threonine kinase counterparts, the tyrosine kinases exploit docking interactions
between kinase domain and substrate and do not achieve specificity solely via the local
sequence surrounding the target tyrosine and/or the canonical interactions between non-
catalytic domains of the kinase and canonical motifs within the substrate.  The idea of a
consensus motif for particular kinase active sites has been extensively pursued and while
some recognition motifs have emerged from studies with short peptides, the results largely
suggest that tyrosine containing peptides are not efficient substrates for the tyrosine kinases
and strict sequences preferences around the target tyrosine are not observed 1,2.
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The discovery of long-range docking interactions for two different tyrosine kinases (Tec
family and Csk) might suggest that local sequence plays little or no role in determining
substrate specificity for this class of enzymes.  Instead, the primary role for the amino acid
sequences surrounding tyrosine phosphorylation sites might be to mediate the interactions
that are induced upon tyrosine phosphorylation.  For example, phosphorylation of the Src tail
by Csk induces critical intramolecular interactions between the phosphorylated tail and the
Src SH2 domain leading to inhibition of Src activity 18-20.  Sequence changes surrounding the
tyrosine in this tail have been shown to modulate the affinity of this intramolecular
interaction and alter kinase regulation 21.  It therefore seems likely that the sequence
surrounding the Csk target tyrosine has evolved to achieve optimal regulation via interaction
with the SH2 domain rather than to serve as an optimal substrate for its cognate kinase.  High
fidelity substrate recognition comes instead from interactions outside of the kinase active site
with regions of the substrate that are removed from the target tyrosine and its neighboring
sequence.  Likewise, phosphorylation of Y783 in PLCg1 has been implicated in formation of
an intramolecular regulatory complex with the adjacent SH2C domain 22.  Thus, the amino
acid sequence surrounding Y783 in PLCg1 might make little or no contribution to substrate
specificity and instead has evolved to achieve the appropriate affinity with its SH2 domain
binding partner following phosphoryation by Itk.  The substrate docking mechanism we have
described for the Itk/PLCg1 pair could therefore provide all of the specificity determining
elements that are required for the Itk kinase to achieve sufficient specificity for its target
during signaling.
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The PLCg1 SH2C domain is one of the most well studied SH2 domains to date.  Its role in
regulating PLCg1 function has been extensively probed (reviewed in 23) and its structure has
been solved in several contexts 24,25.  However, the standard mutagenic approaches used to
probe functional contributions of SH2 domains in general have not uncovered the docking
role of the PLCg1 SH2C domain described here.  The traditional loss-of-function mutagenic
approach for the ubiquitous SH2 domain is to target the conserved arginines in the
phosphotyrosine-binding pocket.  For PLCg1, this approach led to conclusions that the SH2C
domain of PLCg1 is dispensable for recruitment and phosphorylation during signaling 23,26,27.
More recently, the extended experimental approach of Samelson and co-workers showed that
all three SH domains including SH2C are required for phosphorylation of PLCg1 in T cells 28
yet these studies still relied on the mutation of arginine in the phosphotyrosine binding
pocket of the SH2C domain.  In addition, interactions between Itk and PLCg1 have been
previously investigated with an emphasis on classical phosphotyrosine mediated binding by
SH2 domains 29.  Our results now strongly suggest that an alternative, non-canonical surface
of the PLCg1 SH2C domain mediates phosphorylation of the downstream Y783 by docking
onto the Itk kinase domain in a phosphotyrosine independent manner.
The docking site on PLCg1 is highly basic and therefore differs significantly from the only
other tyrosine kinase, Csk, for which substrate docking has been described.  In the case of the
Csk substrate, Src, it has been shown that the recognition motif consists of acidic residues
that are recognized by a basic patch on the Csk kinase domain 8,9.  Moreover, the PLCg1
docking site is not restricted to a continuous stretch of primary sequence.  Mutational
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analysis reveals that residues in both the C-terminus (YRKMKLRYPI) and the CD loop of
the SH2 domain (RAEGK) contribute to a stable docking interaction (Fig. 3a).  Interspersed
between the mostly positively charged residues of both the C-terminus and the CD loop are a
number of hydrophobic side chains that likely contribute to stabilization of the docking
interaction.  Interestingly, the PLCg1 docking site identified here resembles that recognized
by the serine/threonine MAP kinase p38 30.  In that case, alternating hydrophobic and
predominately basic residues make up the recognition motif of MAP kinase targets.
The chemical nature of the PLCg1 docking residues provides clues to possible
docking locations on the Itk kinase domain.  Specifically, it is noteworthy that the small lobe
of the Itk kinase domain contains a cluster of acidic surface residues that might provide the
docking site for substrate recognition.  Further experiments are needed to locate the substrate
docking surface on the Itk kinase domain and to evaluate the interplay between substrate
docking and allosteric control of Itk catalytic activity.  It is nevertheless interesting to note
that for Csk and the serine/threonine kinases (reviewed in 6) distinctly different docking
locations have been described on the catalytic domains (all outside of the catalytic cleft)
suggesting that different kinases solve the problem of substrate fidelity using different
docking platforms.  As the Itk/PLCg1 and additional docking mechanisms for the non-
receptor tyrosine kinase family are further characterized, such differences create potential
opportunities to use small molecules to modulate phosphorylation events and in turn
particular signaling cascades in a highly specific manner that would not depend on
discriminating between similar kinase active sites.  Indeed, we have demonstrated (Fig. 4a)
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that Y783 phosphorylation in full length PLCg1 can be completely inhibited by addition of
an exogenous agent that competes with substrate docking onto Itk.
Methods
DNA constructs and virus production. Production and protein purification using
baculoviral and bacterial Itk and PLCg1 fragments have been described in detail previously
10,31,32.  Full length PLCg1 (wild type or mutants) carrying a strep tag at the C-terminus were
cloned into pENTR/D-TOPO vector (Invitrogen) by TOPO cloning.  All constructs were
verified by sequencing at the Iowa State University DNA Synthesis and Sequencing Facility.
The pENTR vectors were recombined in vitro with BaculoDirect C-Term Linear DNA
(Invitrogen) using the LR Clonase II enzyme (Invitrogen).  The DNA was then transfected
into sf9 cells using Effectene (Qiagen). Three rounds of viral selection and amplifications
were carried out.
Full-length PLCg1 Protein production and purification. Full-length PLCg1 protein
production was similar as before.  Briefly, the insect cells were harvested 72 h postinfection,
rinsed once with phosphate-buffer saline (PBS), and stored at -80°C.  Prior to purification,
cell pellets were resuspended in lysis buffer (20 mM HEPES (pH 7.2), 150 mM NaCl, 2 mM
EDTA, cocktail protease inhibitor) and lysed by sonication.  The total lysate was cleared by
spinning at 14 K at 4°C for 20 min. The supernatant was incubated with strep resin for a
minimum of 2 hours at 4°C. Then the resin was washed with PBS for 4 times and HEPES
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buffer [50 mM HEPES (pH 7.0), 10 mM MgCl2 ] for 2 times.  Then the resin was subjected
to in vitro kinase assay as before10,31,32.
Pull-down assays, in vitro kinase assays and western blot. The protocols used for pull
down assays, in vitro kinase assays and western blot have also all been described previously
10.
CD spectra. Circular dichroism (CD) measurements of the PLCg1 SH2C-linker variants
were performed on a Jasco J-715 CD spectropolarimeter (Jasco Inc.) in the far UV region
(200-260 nm) at 25oC.  Samples were prepared in 10 mM KH2PO4, pH 7.4, at a concentration
of 10 mM as determined by OD280 using an extinction coefficient of 18910 M
-1cm-1.  CD
spectra were recorded at a scanning rate of 50 nm/ min with a spectral bandwidth of 2 nm
and response times of 2 msec.  Ten accumulations were acquired and the results were
averaged. After background subtraction, all the CD data were converted from mdegree into
mean residue ellipticity (deg. cm2 .dmole-1).
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Figure Captions:
Figure 1: (a) Domain structure of full length PLCg1.  The site of PLCg1 phosphorylation by
Itk (Y783) is indicated and the SH2C-linker substrate fragment (residues 659-789) is
highlighted with a grey box.  The SH2C domain fragment (residues 659-756) is boxed. (b)
The free PLCg1 SH2 domain competes directly with phosphorylation of PLCg1 Y783.  Lane
1 contains full length Itk enzyme and the PLCg1 SH2C-linker substrate (SH2C-Y783-)
without additional free SH2 domain.  The anti-pY783 antibody is used to detect extent of
substrate phosphorylation on Y783.  Addition of isolated PLCg1 SH2C domain (but not a
control SH2 domain (derived from Grb2)) to the kinase reaction reduces phosphorylation on
Y783 by competing for the docking site on the Itk kinase domain.  Ratios of free PLCg1
SH2C domain to substrate are 10:1 and 25:1 in lanes 2 and 3, respectively and equivalent
82
ratios of the Grb2 SH2 domain are used as a control in lanes 4 and 5.  Coomassie stain of the
gel and an anti-Itk blot (bottom panels) show protein levels.  (c) Schematic description of
substrate docking mechanism.  Phosphorylation of Y783 in PLCg1 depends on direct binding
of the Itk kinase domain to the PLCg1 SH2C domain.  The docking interaction between Itk
kinase domain and PLCg1 SH2C domain does not occlude the active site of Itk and is
independent of phosphortyrosine recognition by the SH2 domain 10.  (d) Sequence alignment
of the PLCg1 SH2C domain from Bos taurus, Rattus norvegicus, Homo sapiens and Xenopus
(1-4 respectively); PI3K SH2 domain (5) and Grb2 SH2 domain (6).  The secondary
structural elements are shown above the sequences and surface residues targeted for mutation
are indicated with asterisks.
Figure 2 (a) Indicated mutations were introduced into the PLCg1 SH2C-linker substrate used
previously 10. One or five mM PLCg1 SH2C-linker substrate (wild type: lanes 1-3) or
indicated mutants (lanes 4-39) were subjected to in vitro phosphorylation by 475 nM full
length FLAG-tagged Itk enzyme.  Lane 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36 and 39 are
no Itk enzyme controls for the wild type substrate or indicated mutants.  Anti-pY783 blot
indicates extent of PLCg1 substrate phosphorylation by Itk; Coomassie Stain shows substrate
levels and anti-FLAG/anti-Itk blot shows the Itk enzyme levels.  Efficient phosphorylation of
Y783 within the substrate by Itk occurs only when the Itk kinase domain/PLCg1 SH2C
domain docking interaction is intact.  Mutations that disfavor or disrupt the docking
interaction lead to diminished Y783 phosphorylation levels.  (b) CD spectra of purified
substrates (wild type PLCg1 SH2C domain and mutants).
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Figure 3: (a) Results of the mutational analysis shown in Figure 2a are mapped onto the
structure of PLCg1 SH2C domain (PDB: 2PLD 25).  Blue corresponds to those amino acids
for which mutation to alanine disrupts docking onto the Itk kinase domain and subsequent
phosphorylation of Y783.  These docking site residues are labeled and are located on the CD
loop and the C-terminus of the SH2C domain. Orange indicates residues that can be mutated
to alanine with no effect on Y783 phosphorylation.  (b) The docking site is distinct from the
phosphopeptide binding surface.  The structure shown includes bound phosphopeptide in red
with the phosphotyrosine (pY) and specificity pockets (pY+3) labeled and the docking site
residues that were determined by mutation (Fig. 2a) in blue as in (a).
Figure 4:  Full length PLCg1 as substrate.  (a) Phosphorylation of Y783 in full-length PLCg1
is reduced by the addition of isolated PLCg1 SH2C domain but not control SH2 domains.
Full-length PLCg1 was subjected to an in vitro kinase assay using Itk full-length enzyme
alone (lane 1), or with increasing concentrations of PLCg1 SH2C domain. Ratios of free
PLCg1 SH2C domain to substrate are 5:1 or 10:1 (lanes 2 and 3, respectively).   The
remainder of the gel shows the same experiment using alternative SH2 domains at
concentrations that are identical to wild type PLCg1 SH2C as controls.  Lanes 4 and 5
contain, in addition to full length PLCg1 substrate and full length Itk enzyme, the isolated
PLCg1 SH2C domain double mutant K749A/R753A, lanes 6 and 7 contain the isolated
PLCg1 SH2C domain double mutant R748A/K751A and lanes 8 and 9 contain the isolated
Grb2 SH2 domain.  Anti-pY783 antibody is used to detect levels of Itk induced
phosphorylation of Y783, anti-strep antibody indicates the level of the full length PLCg1
84
substrate and anti-Itk antibody is used to confirm Itk enzyme levels.  Coomassie stain shows
protein levels of free PLCg1 wild type or mutant SH2 domains and Grb2 SH2 domain.
Strep-tactin protein on the strep resin runs at the same position as the free SH2 domains,
hence a protein band is evident in lane 1 despite the absnec of free SH2 domain in that
experiment.  (b) Itk mediated phosphorylation of Y783 in full-length PLCg1 is reduced upon
mutation of specific docking residues in the PLCg1 SH2C domain.  Lane 1: Strep-tagged,
wild type full-length PLCg1 is incubated with full-length Itk.  Top panel: Phosphorylation of
Y783 is detected using a phosphospecific antibody (anti-pY783).  The level of enzyme is
shown in the middle panel and the level of substrate (full length strep-tagged PLCg1) is
shown in the bottom panel.  Lane 2 is no Itk enzyme control.  Lanes 3 & 5 are the same
experiment as lane 1 using either the K749A/R753A mutant of full-length PLCg1 (lane 3) or












CHAPTER 4.  A PHOSPHOLIPASE Cg1 INTRAMOLECULAR INTERACTION
REGULATES THE SUBSTRATE DOCKING INTERACTION
Publication will be prepared upon completion of the PLCg1
SH2C-linker complex structure




The SH2 domains in PLCg1 play an important role in the membrane recruitment and
phosphorylation of the PLCg1 enzyme.  It contains tandem SH2 domains, one N-terminal
SH2 (SH2N) and one C-terminal SH2 (SH2C). Our data indicate that SH2C mediates an
intramolecular interaction with the adjacent linker sequence regulating the substrate docking
interaction with the Itk kinase domain.  Like the substrate docking interaction, this
intramolecular interaction is distinct from the canonical SH2/phospholigand interaction.
However the intramolecular interaction does occur through the canonical binding pocket for
phosphotyrosine ligand.  Thus our data indicate that a non-classical interaction can occur
through binding to the canonical interaction pocket of the SH2 domain of PLCg1.
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Introduction
Phospholipase Cg1 (PLCg1) is the enzyme that hydrolyzes phosphatidylinositol (4,
5)-bisphosphate (PIP2) into inositol (1, 4, 5)-triphosphate (IP3) and diacylglycerol (DAG) (1,
2 ).  These second messengers mobilize intracellular Ca2+ and activate protein kinase C,
respectively and subsequently lead to activation of downstream signaling that controls the
cellular responses to external stimuli.  PLCg1 belongs to the phosphoinositide-specific
phospholipase C (PI-PLC) family, which include six families and 14 mammalian PLC
isozymes. These are PLCb (b1-b4), PLCg (g1-g2), PLCd (d1-d4), PLCe, PLCz and PLCh
(h1-h2) (1, 2).  These family members share conserved catalytic domain and contain very
different regulatory domains.
Unlike the rest of the PLC family members, PLCg1 contains Src homology domains,
which include an N-terminal SH2 domain (SH2N), a C-terminal SH2 domain (SH2C) and a
SH3 domain.  The SH2N domain is critical for the membrane recruitment and
phosphorylation of PLCg1 (3-5), which are important for PLCg1 activation.   Furthermore,
the Src Homology domains can also directly regulate PLCg1 activity.  Homma and
coworkers reported that a protein fragment that includes the PLCg1 SH2N, SH2C and the
SH3 domain can inhibit PLCg1 activity and this inhibition derives primarily from an 8-mer
peptide in the SH2C domain (6).  Consistent with this, Carpenter and coworkers reported that
deletion of the SH domains results in a 20- to 100- fold increase in PLCg1 activity (7).
Koblan and coworkers reported that a phosphotyrosine ligand for SH2 domains causes a
conformational change in PLCg1 and also increases lipase activity up to 85% (8, 9).
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By mutating the canonical phosphor-tyrosine binding pocket in the SH2 domains,
numerous studies have found that SH2N is required for the membrane recruitment and
tyrosine phosphorylation of PLCg1, while SH2C is not critical for this event (4, 5).  Our
group previously reported a substrate docking interaction that is mediated by the
PLCg1  SH2C domain. This docking interaction is required for efficient phosphorylation of
the full-length PLCg1 Y783 and it is mediated by an alternative interaction surface that is
different from the canonical phospholigand interaction surface of the SH2C.  Using NMR
spectroscopy, we find an intramolecular interaction within PLCg1 that alters accessibility of
this docking site.  Analysis of the truncation mutants by NMR spectroscopy indicates that the
intramolecular interaction is mediated by the A786NPM789 sequence in the linker region and
residues in the SH2C domain form a hydrophobic binding pocket that overlaps with the
canonical binding pocket for phosphotyrosine ligand although there is no phosphor-tyrosine
in this linker region. Thus our data indicate that a non-classical interaction can occur through
the canonical interaction pocket of the SH2 domain of PLCg1.
Results
The PLCg1/Itk interaction is regulated by an intramolecular interaction within
PLCg1. As previously reported (10) and demonstrated here in Figure 1a and 1b, the PLCg1
SH2C domain interacts directly with the Itk kinase domain in a pull down assay using
purified proteins (Fig. 1b, lane 3, 5 and 7).  Further analysis of the PLCg1 SH2C/Itk kinase
domain interaction reveals that the PLCg1 SH2C-linker construct (contains both the SH2C
domain and the 33 amino acid linker region, Fig. 1a) reproducibly interacts to a lesser extent
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with the Itk kinase domain than does the isolated PLCg1 SH2C domain in pull down assays
conducted under a variety of conditions (Fig. 1b, lane 4, 6 and 8).  The diminished binding of
SH2C-linker to the Itk kinase domain could indicate a regulatory mechanism by which the
Itk kinase/PLCg1 SH2C domain interaction is modulated by conformational changes within
PLCg1 or steric blocking of the docking site.
Nuclear Magnetic Resonance (NMR) is a useful tool to monitor individual amino acid
residues and possible conformational changes and/or changes in chemical environment
induced upon ligand binding.  A comparison of separately acquired Heteronuclear Single
Quantum Coherence (HSQC) spectra for the PLC g1 SH2C domain alone and SH2C-linker
reveals significant chemical shift differences that suggest either interaction between the
SH2C domain and the adjacent linker sequence and/or a conformational change in the SH2C
domain that is induced by the linker sequence (Fig. 1c, 1d and 1e).  The absence of linewidth
changes as a function of concentration of SH2C-linker as well as the measured linewidths in
each of the HSQC experiments (16-19 Hz) provide evidence that the interaction between the
SH2C domain and the adjacent linker occurs in an intramolecular sense.  In addition, we
synthesized a peptide that corresponds to the linker region (Fig. 1a) to assess the extent to
which this peptide sequence interacts in an intermolecular sense with the isolated SH2C
domain.  Minimal chemical shift changes are observed for 15N labeled SH2C upon titration
with the linker peptide (data shown in Fig. 1f and 1g).  Following previously reported
methods (11, 12) we used the small but observable chemical shift changes to extract
dissociation constant and find that the affinity of this peptide for the SH2C domain is quite
low (2.5 mM Kd).  Thus, measured linewidths, the absence of spectral changes with
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concentration and the low affinity of the intermolecular interaction between linker peptide
and SH2C domain are all consistent with an intramolecular interaction between linker and
SH2C domain in the PLCg1 SH2C-linker construct.
Figure 1d and Figure 1e show the SH2C residues that have significant chemical shift
differences upon the association of the adjacent linker.  The linker extends from the C-
terminal of SH2C and both the C-terminus and N-terminus are close in space, therefore it is
reasonable to see the residues from the bA, A helix, AB loop and bB (we call this region
cluster I) exhibit significant chemical shift differences.  These residues are highlighted in
orange in Figure 1e.  In addition to the residues in cluster I, residues from the CD loop, bD,
EF loop and BG loop also exhibit significant chemical shift differences between SH2C and
SH2C-linker (we call this region cluster II).  These residues are highlighted in blue in Figure
1e.  Interestingly, residues in cluster II also exhibit significant chemical shift differences
upon titration of the linker peptide (Fig. 1f).  These residues form a continuous surface (Fig.
1g) that partially overlaps with the surface formed by residues in cluster II in Figure 1e.
Therefore the linker sequence itself can associate with the SH2C domain to some extent
independent of the covalent bond linking the SH2C domain and the following linker
sequence.
To further define the contribution of the linker sequence and the minimal fragment
responsible for regulating the Itk kinase/PLCg1 SH2C domain interaction, four truncated
PLCg1 SH2C-linker mutants were created (Fig. 2a).  For each of the truncation mutants and
the SH2C-linker protein, the interactions with the Itk kinase domain were analyzed using a
pull-down assay.  Comparing the amount of Itk kinase domain that is bound to the various
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immobilized GST tagged PLCg1 SH2C fragments (Fig. 2b, lane 3 to 8), it can be seen that all
of these truncated mutants (Fig. 2b frome lane 5 to lane 8) pull down more Itk kinase domain
than does the PLCg1 SH2C-linker (lane 4).  The smallest difference between the PLCg1
SH2C-linker and the longest truncation mutant PLCg1 SH2C-785 (Fig. 2a) indicated that the
last 4 amino acids A786NPM789 in the linker region are critical for regulating the PLCg1
SH2C/Itk kinase domain interaction.
To reveal any possible interaction and/or conformational change in the series of
truncation mutants, HSQC spectra for two of the truncated mutants, PLCg1 SH2C-770 and
PLCg1 SH2C-785 were chosen to compare with the isolated PLCg1 SH2C domain, SH2C-
linker and also with each other (Fig. 3a, 3b, 3d, 3e and 3g). The comparison indicate that the
chemical shift differences between the PLCg1 SH2C and PLCg1 SH2C-785 and the
differences between the PLCg1 SH2C domain and PLCg1 SH2C-770 are less than that of
SH2C and SH2C-linker and no chemical shift differences between the PLCg1 SH2C-770 and
PLCg1 SH2C-785 are evident. Therefore, data here indicate that the last 4 residues of the
linker region A786NPM789 and the first 14 residues of the linker region interact with and/or
induce a conformational change in the PLCg1 SH2C while there is no interaction between the
PLCg1 SH2C and the linker residues spanning 771 to 785.
Figure 3b and 3e show the observed chemical shift differences between SH2C and
SH2C-770 and chemical shift differences between SH2C and SH2C-785 and the surface plot
of these chemical shift differences are shown in Figure 3c and 3f.  Some residues in cluster I
showed significant chemical shift difference compared with SH2C in both of these truncation
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constructs, therefore the existence of the 14 residues at the N-terminal of the linker sequence
induces the chemical environment change for the residues in cluster I (the bA, aA, AB loop
and bB of SH2C).  Equally interestingly, residues in cluster II exhibit no significant chemical
shift differences from that of SH2C for both of these truncation mutants.  Therefore the
significant chemical shift differences that we observed for residues in cluster II comes from
association with the last 4 residues A786NPM789 in the linker and the significant chemical
shift differences for residues in cluster I come from contacting the 14 residues (or less) at the
N-terminal of the linker.  Consistent with this, the titration of the linker peptide into the
SH2C shows that only cluster II residues (the bC, bD, EF loop and BG loop) exhibit
significant chemical shift in the absence of the covalent link between the PLCg1 SH2C and
N-terminus of the linker (Fig. 1f, highlighted in blue in 1g).
To confirm that the residues A786NPM789 are associating with cluster II residues
(highlighted in blue in the SH2C, in Fig. 1e and 1g), we created a mutant in which N787MP789
were mutated to Ala.  If indeed A786NPM789 are responsible for the association, the mutation
should break up the interaction and therefore the residues from cluster II region (the bC, bD,
EF loop and BG loop) should have similar chemical shift resonance as those in the isolated
SH2C domain.  An HSQC spectrum of this mutant was acquired and compared with those of
the SH2C and SH2C-linker revealing that the residues in cluster II in the mutant have almost
same chemical shift resonances as in the isolated PLCg1 SH2C, while residues in cluster I
(the bA, aA, AB loop and bB strand) still have different chemical shift resonances from both
SH2C and SH2C-linker (Fig. 4a, b, c and d). Thus the last 4 residues in the linker are indeed
critical for interacting with the PLCg1 SH2C domain.
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Because of the putative regulatory role of the last 4 amino acids A786NPM789 played
in the substrate docking interaction, we mapped the residues in the SH2C that are associating
with A786NPM789 (the residues that showed significant chemical shift in Fig. 1d and 1f and
highlighted in blue in Fig. 1e and 1g) onto the structure of the SH2C domain (Fig. 5a) (13).
F706 is located at the bC strand of the SH2C domain; E709 resides on the CD loop; K713,
H714, C715 and V717 are from the bD strand; G727 is from the EF loop, and H744, L746
and Y747 are from the BG loop.  Comparison of the surface that is mapped here with the
substrate docking surface (Fig. 5b, also see Chapter 3 for detailed information) indicates they
are partially overlapped, which might explain the diminished interaction between the SH2C-
linker and the Itk kinase domain.  Meanwhile, it is also plausible that the association of the
residues at the C-terminal of Y783 with SH2C restricts the access of Y783 and therefore we
can speculate that the mutation that disrupts the intramolecular interaction will make the
SH2C-linker or full-length PLCg1 a better substrate for Itk.  
Viewing the residues that are mediating the intramolecular interaction on the SH2C
structure indicates that these residues form a hydrophobic groove in the SH2C domain (Fig.
5a).  Comparing the intramolecular interaction surface with a phosphotyrosine peptide bound
SH2C domain (Fig. 5c) reveals that the intramolecular interaction surface overlaps with the
canonical binding pocket for phosphotyrosine ligand.  This suggests that association of the
linker residues with the SH2C domain could regulate the canonical SH2C/phosphotyrosine
interaction and vice versa.
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Discussion
The NMR structure of PLCg1 SH2C bound to a phosphotyrosine peptide from
platelet-derived growth factor (PDGF) was one of the first SH2 domain structures solved
(13).  More recently PLCg1 SH2C bound to a peptide that contains two phosphotyrosines has
been solved by NMR (14).  Both of these structures represent phosphotyrosine mediated SH2
interactions.  Unlike the canonical SH2/phosphotyrosine interaction, the intramolecular
interaction between PLCg1 SH2C and the adjacent linker does not involve phosphorylated
Tyr. Therefore the intramolecular interaction is mediated by an interaction mechanism that is
distinct from the canonical SH2/phospholigand interaction.  Solving the structure of SH2C-
linker to understand the detailed molecular mechanism of intramolecular interaction and its
regulation of the substrate docking interaction will be important for us.  However, the solving
the structure of this SH2C-linker complex presents challenges due to the exchange
broadening that diminishes the quality of the NMR spectra.  Different pulse sequences to
suppress relaxation during transfer are currently being explored. We will also design
mutations to attempt to modify the dynamic exchange regime based on our data for the
intramolecular interaction.  As well, we have attempted crystallization of SH2C-linker
complex but thus far been unsuccessful.  The inability to crystallize SH2C-linker complex is
consistent with the dynamic exchange behavior observed by NMR.
Our data indicate that conformational rearrangements and/or steric blocking by the
linker sequence within the PLCg1 substrate can mask the docking site for the Itk kinase
domain contributing to a complex set of regulatory interactions that maintain fidelity in TCR
signaling.  Intramolecular association of the PLCg1 SH2C domain and the neighboring linker
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region was first proposed by Rhee and co-workers (15).  In that work it was shown that
phosphorylated Y783 (pY783) associates with SH2C in the same molecule and the authors
suggested a regulatory role for this canonical intramolecular binding of SH2C.  More
recently, Rellahan and co-workers provide biochemical data for an autoinhibitory mechanism
involving both the SH2C domain and the amino terminal split PH domain (16).  In our work
here we reported that an intramolecular interaction between SH2C and the last four residues
in the linker region A786NPM789.  It will clearly be important to reconcile all of these
interactions, both canonical and non-canonical, in further studies of regulation in full length
PLCg1.  In the context of the results we present here, we can propose that an autoinhibitory
conformation of PLCg1 likely involves an intramolecular interaction between SH2C and its
adjacent linker region. This intramolecular complex might control phosphorylation of Y783
by modulating accessibility of the docking site to the Itk kinase domain and possibly by
modulating the accessibility of Y783 itself.  Further structural characterization of this
intramolecular regulatory conformation will reveal precisely how the substrate docking site
on PLCg1 SH2C can be masked by the adjacent region of PLCg1 providing an additional
layer of control during T cell activation.
The function of SH2 domains is most often probed by mutating the universally
conserved Arg in the phosphotyrosine binding pocket.  For PLCg1 SH2C, this traditional
loss-of-function mutagenesis approach has led to the conclusion that SH2C is not critical for
many cellular events involving PLCg1 (4, 5).  It is interesting that the interactions that we
described for PLCg1 SH2C, the docking interaction that is described in Chapter 2 and 3 and
the intramolecular interaction between PLCg1 SH2C domain and the adjacent linker
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described in this chapter, are both independent of phosphotyrosine.  Our results support the
idea that the function of PLCg1 SH2C domain is versatile and SH2C can mediate both
canonical SH2/phosphotyrosine interactions and noncanonical interactions with ligands that
do not contain phosphotyrosine.   Thus the commonly used criteria for judging SH2 domain
function by mutating the conserved phosphotyrosine ligand-binding pocket might be
misleading and misguide the interpretation of SH2 domain function in general.
Materials and Methods
Protein production and purification.  Production and protein purification using
baculoviral and bacterial Itk and PLCg1 constructs have been described in detail previously
(10).
Pull-down assays and western blot.  The protocols used for pull down assays and
western blotting have also all been described previously (10).  All peptides were obtained
from Genscript.  Peptide concentrations were confirmed by amino acid analysis at the Iowa
State University protein facility.
NMR spectra acquisition. NMR Spectra were acquired using a Bruker AVII 700
spectrometer equipped with a 5mm HCN cryoprobe operating at 700.133 MHz 1H frequency.
All spectra were obtained at 303K.  Backbone NH resonances were confirmed for PLCg1
SH2C and assigned for SH2C-linker using 15N-edited NOESY, TOCSY, HNCA, HNCOCA,
HNCACB and CACBCONH.  2D 1H-15N HSQC spectra (17) acquired for PLCg1 SH2C,
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SH2C-linker and truncation mutant were compared and differences in 1H and 15N chemical
shifts were quantified using the formula (18): D dave = {[½ [(DdH)2 + (0.2DdN)2]}1/2.
Residues with chemical shift changes above the mean plus one standard deviation were
considered significant.  1H and 15N chemical shifts were externally referenced to DSS in
identical buffer.  Additionally, 3D 15N-edited NOESY spectra were obtained for both SH2C
and SH2C-linker.  Full analysis of these data is underway in the context of structure
determination but clear differences for certain residues are noted herein.  NMR samples were
prepared in identical buffer: 50 mM KH2PO4, pH 6.4, 150 mM NaCl, 2 mM DTT, 0.02%
NaN3.
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Figure Caption
Figure 1: PLCg1 SH2C and the adjacent linker interact intramolecularly. (a) Schematic of
PLCg1 SH2C, PLCg1 SH2C-linker and the linker peptide.  The 33 amino acid linker located
at the carboxy-terminus of the SH2C domain contains Y783 (boxed) that is phosphorylated
by Itk.  (b) The Itk kinase domain (KD) interacts with PLCg1 SH2C-linker to a lesser extent
than with SH2C at various conditions.  Purified FLAG-tagged Itk KD (lane 1) was incubated
with GST (lane 2), GST-SH2C (lanes 3, 5 and 7), GST-SH2C-linker (lanes 4, 6 & 8). The
conditions of each pull-down experiment were varied.  Specifically, the SH2C and SH2C-
linker were purified either using PBS buffer (lanes 3 & 4) or HEPES buffer (lanes 5-8) and
the salt concentration varied from 150 mM NaCl (lanes 2, 3 and 4) to 0.5 M NaCl (lanes 5 &
6) to 1 M NaCl (lanes 7 & 8).  The amount of flag tagged Itk KD bound to immobilized GST,
GST-SH2C or GST-SH2C-linker is detected using an anti-FLAG antibody and the levels of
GST, GST-SH2C and GST-SH2C-linker are detected by Ponceau S stain.  (c) 1H-15N HSQC
spectra of PLCg1 SH2C (black) and PLCg1 SH2C-linker (red).  Backbone resonance
frequencies differ significantly for these two proteins indicating an association between the
SH2C domain and the adjacent linker sequence.  (d) Chemical shift differences between
SH2C and SH2C-linker (derived from HSQC spectra shown in c).  The differences in
chemical shift between SH2C and SH2C-linker were quantified using the formula (18): Ddave
= {[½ [(DdH)2 + (0.2DdN)2]}1/2.  The horizontal lines indicate mean plus one standard
deviation.  Chemical shift differences greater than the mean plus one standard deviation are
considered significant.  Proline residues at positions 686, 699, 746 and 755 do not appear in
the HSQC data.  N700 and K749 are not assigned and are therefore not included in this
analysis.  Secondary structures are indicated above the protein sequence.  Residues from the
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bA, aA, bB and AB loop are in cluster I; residues from the CD loop, bD, EF loop and BG
loop are in cluster II.  All of the chemical shift difference data are processed in the same way
throughout this chapter.  (e) A surface plot of the chemical shift differences between SH2C
and SH2C-linker.  The SH2C (PDB ID 2PLD) is shown in grey and the residues that exhibit
significant chemical shift in cluster I are highlighted in orange; residues that exhibit
significant chemical shift in cluster II are highlighted in blue.  The color scheme is same for
all of the surface plots throughout this chapter.  (f) Chemical shift changes upon titrating
linker peptide into SH2C.  The presence of linker peptide induced chemical shift changes for
residues in cluster II.  (g) A surface plot of the chemical shift changes upon linker peptide
binding.  It can be seen that all the residues that exhibit significant chemical shift changes are
in cluster II.
Figure 2: The last 4 residues in the linker sequence are critical for regulating the docking
interaction.  (a) Schematic of PLCg1 SH2C-linker, the truncation mutants and SH2C.  The
number above the linker residues indicates the amino acid number in the full-length PLCg1
protein. (b) All of the truncation mutants interact with the Itk kinase domain (KD) to a
greater extent than does the SH2C-linker.  Purified FLAG-tagged Itk KD (lane 1) was
incubated with GST (lane 2), GST-SH2C (lanes 3), GST-SH2C-linker (lanes 4) and different
truncation mutants (lane 5, 6, 7 and 8 respectively). The conditions of each pull-down
experiment were same as that of lane 2-4 in figure 1b.  Specifically, the SH2C and SH2C-
linker were purified either using PBS buffer (lanes 3 & 4) and the salt concentration 150 mM
NaCl.  The amount of flag tagged Itk KD bound to immobilized GST, GST-SH2C, GST-
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SH2C-linker and different truncation mutant is detected using an anti-FLAG antibody and
the levels of GST, GST-SH2C and GST-SH2C-linker are detected by Ponceau S stain.
Figure 3. The last 4 residues in the linker sequence associate with the SH2C domain.  (a) 1H-
15N HSQC spectra of PLCg1 SH2C (black) and truncation mutant PLCg1 SH2C-770 (blue).
The backbone resonance frequency difference between SH2C and SH2C-770 is less than that
of SH2C and SH2C-linker.  (b) Chemical shift difference between SH2C and SH2C-770
(derived from HSQC spectra shown in a).  All the residues that exhibit significant chemical
shift are in cluster I and they are highlighted in orange in Fig. 3c.  (c) A surface plot of the
chemical shift differences between SH2C and SH2C-770.  (d) 1H-15N HSQC spectra of
PLCg1 SH2C (black) and truncation mutant PLCg1 SH2C-785 (purple). The backbone
resonance frequency difference between SH2C and SH2C-785 is less than that of SH2C and
SH2C-linker.  (e) Chemical shift difference between SH2C and SH2C-785 (derived from
HSQC spectra shown in d).  Like Fig. 3b, only residues in cluster I show significant chemical
shift difference and these residues are highlighted in orange in Fig. 3f.  (f) A surface plot of
the chemical shift differences between SH2C-785 and SH2C.  (g) 1H-15N HSQC spectra of
the two truncation mutants PLCg1 SH2C-771 (blue) and SH2C-785 (purple).  Backbone
resonance frequencies are same for these two proteins except there are more peaks in SH2C-
785 (the purple spectrum) indicating no association between the SH2C domain and the
middle 15 amino acids in the linker sequence.
Figure 4:  Mutation of NPM partially disrupts the association of linker with SH2C domain.
(a) 1H-15N HSQC spectra of PLCg1 SH2C (black), SH2C-linker (red) and SH2C-linker
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NPM_AAA mutant (magenta).  In SH2C-linker NPM_AAA mutant, some residues have
similar chemical shift resonance with that in the SH2C and some residues have different
chemical shift resonances from both the SH2C and SH2C-linker.  (b) Residue H714 in the
bD strand in SH2C-linker NPM_AAA (magenta) has almost same chemical shift resonance
with that in the SH2C.  (c) Residue G727 from the EF loop in SH2C-linker NPM_AAA has
almost same chemical shift resonance with that in the SH2C.  (d) Residue V683 in the AB
loop that has different chemical shift resonance from that of both SH2C and SH2C-linker.
Figure 5: The interaction surface for the last 4-linker residues partially overlaps with the
substrate docking interaction surface.  The association of the last 4 residues in the linker
region with SH2C is mediated through a surface that partially overlaps with the canonical
binding pocket for phosphotyrosine peptide. (a) A surface plot of the binding pocket for the
last 4 residues.  The highlighted surface is composed of all of the residues that are
highlighted in blue in Fig 1e and 1g.  (b) A surface plot of the docking site residues. The
SH2C is shown in grey and the docking residues are shown in green. (c) A surface plot of
structure SH2C bound to a phosphotyrosine lignad (2PLD). The SH2C is shown in grey and
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Abstract
Protein tyrosine kinases are responsible for producing phospho-tyrosine sites in many
signal transduction processes.  The regulation of the immunological non-receptor tyrosine
kinase, Interleukin-2 tyrosine kinase (Itk), is not yet well understood.  Here we show that full
length Itk self-associates in an intermolecular fashion and that sequence changes in the SH3
domain reduce the extent of self-association.  Results of in vitro kinase assays indicate that
the activity of wild-type, full-length Itk is reduced at higher enzyme concentrations while the
full-length Itk-SH3 mutant exhibits enzymatic activity that increases linearly with increasing
enzyme concentration.  When expressed in insect cells, the full-length Itk-SH3 mutant
phosphorylates the Itk substrate PLCg1 better than wild-type Itk.  Furthermore, expression of
the full-length Itk-SH3 mutant in primary T cells induced higher ERK activation following
TCR stimulation than wild-type Itk.  Our results suggest that the protein tyrosine kinase Itk
can be negatively regulated by intermolecular clustering.
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Introduction
Interleukin-2 tyrosine kinase (Itk) is a non-receptor protein tyrosine kinase of the Tec
family that is expressed in T cells, mast cells and NK cells (1-5).  This kinase participates in
signaling processes following T cell receptor engagement by phosphorylating phospholipase
C-g1 (PLC-g1) (6-9).  In addition to Itk, the Tec family kinases include Btk, Tec, Rlk and
Bmx, each of which shares a similar domain structure with the Src kinase family (10).  Both
families contain a Src homology 3 (SH3) domain, a Src homology 2 (SH2) domain and the
catalytic domain.  With the exception of Rlk, the Tec kinases also contain a pleckstrin
homology (PH) domain and a tec homology (TH) domain at the amino terminus.  A
significant difference between the Src and Tec kinases is that the Tec kinases lack the
carboxy-terminal autoinhibitory sequence that serves to negatively regulate the Src kinases.
The absence of a Src-like regulatory tail in Itk and related family members raises questions
as to how the Tec kinases are turned off during the course of T cell signaling.
We and others have previously reported detailed structural studies for regulatory
domain fragments of Itk, Btk, Tec and Rlk (11-19).  An emerging theme for each of these
kinases is that the non-catalytic domains form dimeric and higher order oligomeric structures
in solution.  For Itk, self-association of the regulatory domains occurs via intermolecular
interactions between the SH3 domain and the SH2 domain (12).  An intermolecular
interaction has also been described for the Itk PH domain (20).  The isolated PH domain
interacts both with itself and with the PH domain within full length Itk in co-
immunoprecipitation experiments.  Finally, a split YFP system has previously allowed
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visualization of intermolecular interactions between full-length Itk molecules in cells (21).
Thus, abundant data point to intermolecular clustering of Itk, most likely mediated by
multiple Itk regulatory domains; yet to date, the functional significance of this self-
association has not been investigated.
Here, we first extend the earlier studies of Itk domain fragments and demonstrate that
full-length Itk self-associates in an intermolecular fashion in vitro.  To evaluate the functional
significance of the observed self-association, we then designed a mutant Itk molecule that
retains all of the structural features of the wild-type enzyme, yet exhibits diminished self-
association.  Analysis of the catalytic activity of the non-clustering mutant compared to wild-
type indicates that the self-association of wild-type Itk results in decreased kinase activity.
Given the necessary concentration dependence of intermolecular Itk clustering, we examined
the signaling properties of wild type and mutant Itk following expression in Itk-/- primary
CD4+ T cells, thus avoiding complications that would arise from over-expression conditions.
In addition, this system allowed us to test Itk function in T cells expressing homogeneous
populations of mutant or wild-type Itk, instead of a mixed population of Itk molecules, as
would arise following expression of the mutant Itk construct in Itk-sufficient T cells.  The
results of these experiments indicated that the Itk mutant exhibiting diminished self-
association and increased in vitro kinase activity also had increased signaling function upon
T cell receptor engagement in primary T cells.  We discuss mechanistic explanations for this
observation and a model for the control of Itk activity during T cell receptor signaling.
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Experimental Procedures
Constructs and baculovirus production. V5 or myc tagged proteins were cloned into the
pcDNA3.1D/V5-His-TOPO vector (Invitrogen). Itk (BtkSH3) chimera was generated by
replacing Itk SH3 domain sequence from Pro171 to Asn232 with the human Btk sequence
spanning Ser214 to Ser275 by PCR. Flag tagged full-length wild-type (mouse Itk) or Itk
(BtkSH3) chimera were cloned into the pENTR/D-TOPO vector (Invitrogen) by TOPO cloning.
The point mutations were introduced using the QuickChange Site-Directed Mutagenesis Kit
(Stratagene).  The pENTR vectors with various inserts were recombined in vitro with
BaculoDirect C-Term Linear DNA (Invitrogen) according to the manufacturers instructions
(Invitrogen) for virus production.  The PLCg1 baculovirus has been described previously (9).
Immunoprecipitation and western blot. NIH 3T3 cells were transfected with myc or V5
tagged DNA using EffecteneTM transfection reagent from Qiagen. Twenty-four hours post
transfection, cells were lysed in buffer containing 0.5% NP 40, 50mM Tris (pH 7.4), 150mM
NaCl, 10mM MgCl2, and protease inhibitors (Roche Applied Science). Immunoprecipitaiton,
western transfer and western blotting were performed using standard techniques.
Protein expression and purification. The purification method for bacterially expressed
protein has been described previously (12). For Sf9 protein expression, baculoviruses for full-
length wild-type Itk or the Itk(BtkSH3) chimera along with Lck virus were used to infect Sf9
cells in a 1:1 ratio.  Proteins were purified using methods reported previously (22-24).  The
concentration of purified protein was measured by absorbance at 280 nm using an extinction
coefficient for Itk of 118570 M-1cm-1.
NMR spectroscopy. NMR spectra were recorded at 298 K on a Bruker DRX500 spectrometer
operating at a 1H frequency of 499.867 MHz. Protein concentrations were adjusted to 1 mM.
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Global least squares parameter fitting of the titration data was performed using the Matlab
(version 5.3.1, The Mathworks Inc.) suite of programs.  
Phosphorylation status. Purified wild-type full-length Itk, Itk(BtkSH3) and Y180F full-length
Itk were subjected to autophosphorylation assays by incubation at room temperature in a
buffer containing 50mM Hepes (pH 7.0), 10mM MgCl2, 1mM DTT, 1mg/ml BSA, 0.2mM
ATP at RT for 30min at 0.8 mM final enzyme concentration. The reaction was stopped by the
addition of SDS-loading dye, run on an SDS-PAGE gel and western blotted.
Kinase assay.  The method (described in (22)) is adapted from previous in vitro kinase assays
developed for Itk (23,24). Biotin labeled peptide-B (AnaSpec Inc.), was used as a substrate in
all of the in vitro kinase assays. For the determination of Km for peptide B, substrate
concentration was varied from 10 mM to 400 mM. The wild-type and chimeric Itk exhibit
similar Km and kcat at low concentrations of enzyme (100 nM).  For initial velocity
measurements at varying enzyme concentrations, the peptide B concentration was maintained
at 400 mM. Km and Vmax were determined by fitting the data to the Michaelis-Menton
equation using the enzyme kinetics module of the Graph Fit 5 program.
Purification of primary CD4+ T cells.  Spleen and lymph node cells were isolated from Itk-/-
(6) mice, and CD4+ T cells were purified by positive selection using anti-CD4 antibody-
coated magnetic microbeads (Miltenyi Biotec).
Retrovirus production.  Itk and Itk(BtkSH3) were cloned into the retroviral mouse stem cell
virus vector MSCV2.2-IRES-GFP (25).  Phoenix-E retroviral packaging cells were
transfected with each retrovirus construct plus the pCL-Eco retrovirus Packaging vector
(Imgenex) as described previously (9), and virus particles were harvested and stored at -
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80oC.  For each infection, 2 x 106 primary CD4+ T cells were stimulated with 5ng/ul of PMA
(Sigma) and 375ng/ul of Ionomycin (Calbiochem) for 24 hrs and then incubated with 2ml of
viral supernatant plus IL-2 (30ng/ml) and lipofectamin (Invitrogen).  After 3-4 days,
CD4+GFP+ infected cells were sorted by flow cytometry and cultured a further two weeks in
IL-2.  For analysis, 3 x 106 cells were restimulated by incubation with biotinylated-anti-CD3
Ab (25 mg/ml) for 10 min, followed by strepavidin (50 mg/ml) crosslinking for 5 min.  Cell
lysates were analyzed for phospho-ERK by immunoblot; alternatively cells were
permeabilized and stained with anti-phosphoERK antibody (Cell Signaling) followed by flow
cytometry.
Results
Full-length Itk self-associates via intermolecular interactions between the non-
catalytic regulatory domains.  We have previously reported that the singly expressed Itk SH3
and SH2 domains interact in an intermolecular fashion (12).  The interaction surfaces that
mediate this binding event have been pinpointed through the analysis of NMR chemical shift
perturbations.  The regions involved in the interaction include the conserved binding cleft of
the SH3 domain and a surface that only partially overlaps with the well-characterized
phosphopeptide binding surface of the SH2 domain (Fig. 1a).
In an effort to first determine whether the intermolecular Itk SH3/SH2 interaction
mediates self-association of the full-length Itk kinase, we generated differentially tagged
versions of full- length, wild-type Itk for co-immunoprecipitation experiments in NIH 3T3
cells (Fig. 1b).  The myc and V5 epitope tagged Itk constructs were both transiently
transfected into NIH 3T3 cells and subjected to immunoprecipitation using anti-myc
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antibody.  The immunoprecipitated fraction was then resolved by SDS-PAGE and probed
with an antibody to the V5 tag.  As a control, NIH 3T3 cells were also transiently transfected
with V5 tagged Itk and/or the empty vector alone.  Consistent with intermolecular self-
association of full-length wild-type Itk, V5 tagged full-length Itk is readily detected in anti-
myc immunoprecipitates from co-transfected NIH 3T3 cells (Fig. 1b).  This data is also
consistent with previous in vivo data that indicates intermolecular association of full length
Itk molecules (21).  
To directly probe the contribution of the catalytic domain of Itk to the observed self-
association, the Itk kinase domain alone was separately tagged with myc and V5, co-
transfected into NIH 3T3 cells, and treated in the same manner as described above for full-
length Itk.  In contrast to the full-length protein, the co-immunoprecipitation experiment
provides no evidence for self-association of the isolated kinase domain (Fig. 1c).  This result
suggests that the non-catalytic regulatory domains of Itk are the primary determinant of
intermolecular self-association of the full-length protein.  We therefore turned our attention
to the structural features of the SH3/SH2 intermolecular interaction to identify sequence
changes that might disrupt Itk self-association when incorporated into the full-length
molecule.
Itk SH3 domain interacts specifically with the Itk SH2 domain.  The regulatory SH2
and SH3 domains of Itk interact via an intermolecular association that does not fit the
established paradigms for SH2 or SH3 recognition (12).  The SH3/SH2 interaction is neither
phosphotyrosine-dependent nor mediated by a polyproline motif.  Given the non-canonical
nature of this interaction, Itk presents an ideal target to specifically disrupt self-association by
incorporating sequence changes into the SH3 and/or SH2 domains that do not affect binding
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to canonical proline-rich or phosphotyrosine ligands.  Mutations that selectively disrupt self-
association would permit functional assays to compare full-length, wild-type Itk that interacts
with itself in an intermolecular fashion (Fig. 1b) to a full-length Itk variant in which self-
association is selectively disfavored.
Molecular determinants of the SH3/SH2 interaction.  In an effort to identify sequence
changes that will abrogate the interaction between the Itk SH3 and SH2 domains, we first
considered a point mutation in the well characterized SH3 binding cleft that would affect the
interaction between the singly expressed SH2 and SH3 domains.  Mutation of the central
residue in the SH3 binding cleft, Trp 208, has been previously shown to disrupt the
interaction between the SH2 domain and SH3 domain of Itk (12) and therefore might also
diminish the extent of full length Itk oligomerization.  However, this conserved tryptophan
also makes extensive contacts to cognate proline-rich ligands (26,27) and is therefore not an
appealing target for mutation in our current study.  Instead, we turned our attention to an
approach that would disrupt Itk self-association but maintain the canonical ligand binding
characteristics of the Itk regulatory domains.
The Btk SH3 domain is 51% identical to that of Itk.  Of the Itk SH3 domain surface
residues that contact the Itk SH2 domain (Fig. 1a), there are eight residues that differ
between Itk and Btk SH3 domains (Fig 2a).  These sequence differences are enough to
eliminate the intermolecular SH3/SH2 interaction; no chemical shift perturbations are
observed in NMR spectra upon mixing the Btk SH3 domain with the Itk SH2 domain at
concentrations required for NMR analysis (Fig. 2b).  Canonical proline-rich binding was
tested next.  We compared the affinities of the Itk and Btk SH3 domains for a proline-rich
peptide derived from Slp-76 (Q184QPPVPPQRPMA195) and previously shown to bind the
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SH3 domain of Itk (28).  Separate titrations of the QQPPVPPQRPMA peptide into 15N
labeled Itk or Btk SH3 domains induced chemical shift perturbations that were analyzed to
determine the respective dissociation constants.  The binding curves generated upon addition
of increasing concentration of the Slp-76 peptide into the Btk and Itk SH3 domains (Fig. 2c)
are indistinguishable.  Thus, the Btk SH3 domain does not interact with the Itk SH2 domain
yet maintains normal proline binding characteristics.  This data provides a strategy for
altering the full-length Itk sequence to disfavor the observed self-association of wild-type Itk.
A full-length chimeric Itk protein (designated Itk(BtkSH3)) that contains the Btk sequence
within the region that normally spans the Itk SH3 domain (Fig. 2d) was constructed.  All
other regions of Itk(BtkSH3) are identical to wild-type full-length Itk.
Btk SH3 sequence limits Itk self-association. In a manner identical to the wild-type Itk
sequence, myc and V5 epitope tagged Itk(BtkSH3) constructs were transiently transfected into
NIH 3T3 cells and subjected to co-immunoprecipitation.  Consistent with the absence of an
intermolecular interaction between the isolated Itk SH2 domain and the Btk SH3 domains in
Figure 2b, co-immunoprecipitation data indicate that full-length Itk(BtkSH3) does not self-
associate to a level that is detected in the co-IP experiment (Fig. 1d).  Efforts to further
characterize purified Itk and Itk(BtkSH3) by analytical ultracentrifugation were complicated by
the presence of multiple self-associating species for both wild type Itk and Itk(BtkSH3)
potentially due to the high concentrations required for ultracentrifugation (over 10-fold that
of the co-IP experiment) and the known self-association of the PH domain (20).  Regardless,
the differences in the co-IP data for Itk and Itk(BtkSH3) (Fig. 1b & d) suggest that disruption of
the non-canonical Itk SH3/SH2 interaction reduces intermolecular self-association of full-
length Itk compared to wild type protein.  These observations prompted us to proceed toward
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an examination of the kinase activities of full length Itk and Itk(BtkSH3) to assess the functional
significance of altering Itk intermolecular self-association.
Prior to functional characterization of the full-length chimeric Itk protein we set out
to confirm that the sequence changes required to replace the SH3 domain in full-length Itk
with that of Btk do not drastically modify the enzyme.  We examined the phosphorylation
status of both Tyr 511 in the Itk activation loop and Tyr 180 within the SH3 domain.
Phosphorylation at both sites accompanies activation of Itk in T cells (9) and if disrupted
could produce unwanted ancillary effects on Itk functional assays in cells.  Phosphorylation
assays using antibodies specific to the phosphotyrosines of interest reveal that both Itk and
Itk(BtkSH3) are phosphorylated at the expected sites; Tyr 180 (Fig. 3a) and Tyr 511 (Fig. 3b).
Thus, sequence changes in the full length Itk(BtkSH3) diminish intermolecular self-association
but do not alter the normal phosphorylation patterns associated with wild type Itk activation.
Intermolecular self-association negatively regulates Itk activity in vitro and in vivo.
Next, recombinant flag tagged wild-type Itk and Itk(BtkSH3) were separately purified from
baculovirus-infected insect cells and used for in vitro kinase assays.  In an in vitro kinase
assay that we have described previously for wild-type Itk (22), a biotinylated peptide
substrate (24) was used to measure the initial velocity of each protein over a range of enzyme
concentrations (Fig. 3c).  The concentration of peptide substrate in these assays is 400 mM
(~five times Km), to ensure that substrate is not limiting (22).  Itk(BtkSH3) gives rise to a linear
increase in enzyme activity as a function of increasing enzyme concentration (Fig. 3c).  In
contrast, the initial velocity of full-length wild-type Itk increases linearly at lower enzyme
concentrations but begins to deviate from linearity at 1 mM and above (Fig. 3c).  At these
higher concentrations of wild-type Itk, the catalytic activity deviates from linearity in a
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negative direction suggesting that increased concentration of the wild-type enzyme
diminishes Itk kinase activity.  The observed differences in the enzymatic activity of the
wild-type and Itk(BtkSH3) and differences in the extent to which these proteins self-associate in
the co-immunoprecipitation experiment (Fig. 1d) suggest that intermolecular interactions
mediated by the SH3 and SH2 domains of Itk serve to negatively regulate Itk catalytic
activity.
To test whether the findings from the in vitro kinase assay are borne out in a more
physiological context, we first co-infected Sf9 insect cells with the Itk substrate, PLC-g1, and
either wild-type Itk or Itk(BtkSH3).  Tyrosine phosphorylation of PLCg1 on Tyr783 was more
robustly induced by Itk(BtkSH3) than by wild-type Itk, consistent with enhanced kinase activity
for Itk(BtkSH3) on its native substrate (Fig 4a).
Wild-type Itk and Itk(BtkSH3) were then introduced into Itk
-/- primary CD4+ T cells by
retrovirus transduction; using this retrovirus vector, GFP is translated from the same mRNA
transcript as Itk.  Importantly, Itk and Itk(BtkSH3) were expressed at comparable levels in Itk
-/-
deficient cells, as indicated by GFP fluorescence (Fig. 4b).  Previous studies have shown that
optimal activation and phosphorylation of the p42/44 ERK Map-kinases following T cell
activation are dependent on Itk (8,29).  To compare wild type Itk and Itk(BtkSH3) function in
primary T cells, transduced T cells were stimulated by T cell receptor (TCR) engagement,
and ERK phosphorylation was assessed.  Itk-/- T cells expressing wild-type Itk were ~20%
positive for ERK phosphorylation, in contrast to Itk-/- T cells transduced with the retrovirus
vector alone (~10% phospho-ERK+).  Expression of Itk(BtkSH3) further enhanced ERK
activation, leading to ~30% phospho-ERK+ cells.  Average data from three experiments are
shown in Figure 4c.  Of note, the level of Itk(BtkSH3) in retrovirus-infected Itk
-/- T cells is
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lower than the normal level of endogenous Itk in wild-type T cells (Fig 4d).  Nonetheless,
even this low level of Itk(BtkSH3) induces ERK phosphorylation that is similar if not greater
than that seen in wild-type T cells following TCR stimulation (Fig 4d).  These data indicate
that Itk(BtkSH3) is able to function in the TCR signaling pathway of primary T cells and
compared to wild type Itk expressed at the same level, the non-clustering Itk mutant exhibits
enhanced TCR signaling.
It is clear that intermolecular self-association of Itk is a concentration dependent
phenomenon and it therefore would be useful to have some measure of Itk concentration in T
cells.  Using quantitated immunoblots of SDS-PAGE-separated cellular lysates derived from
a known number of Jurkat E6.1 cells (not shown), purified Itk as a concentration standard,
and information from microscopy studies of Jurkat E6.1 cells estimating the cytosolic
volume to be 2.4 picoliters (Jon Houtman, personal communication), we estimate that Itk
concentration in Jurkat T cells is between 0.2 and 0.4 mM.  The difference between the
concentration range for which we observe activity changes in vitro and this rough estimate of
Itk concentration in T cells is a factor of 2.5 to a factor of five; less than one order of
magnitude.  Studies aimed at measuring global and local concentrations of cellular proteins
indicate that global cytoplasmic concentrations can range from tens of nM to mM while local
accumulation of certain proteins can result in several orders of magnitude increase in protein
concentration (tens of mM to mM) (30,31).  Thus, even without taking local increases in Itk
concentration into account, we can surmise that the concentration of Itk in the cytosol of the




Strength and duration of TCR signaling are important in regulating T cell
development and lineage commitment.  As a key component of the TCR signaling pathway,
Itk has been found to modulate several aspects of thymocyte maturation, including positive
selection, negative selection, and conventional versus innate CD8+ T cell development
(32,33).  These observations suggest that Itk activity is involved in fine-tuning TCR
signaling, and that this, in turn, regulates T cell fate decisions.  Further investigation of this
process would be greatly aided by a mouse model in which Itk kinase activity is increased
relative to wild-type Itk.
Previous efforts to increase Itk activity by overexpression have uniformly been
unsuccessful (28).  The data presented in this report provide a biochemical explanation for
these failures, and further suggest that a knock-in mouse expressing Itk(BtkSH3) (or a second
generation mutant that further skews the equilibrium away from clustered Itk) in place of
wild-type Itk could provide a system for examining T cell development and lineage
commitment in cells with increased Itk kinase activity.  To our knowledge, Itk(BtkSH3) is the
first Itk variant to show activity greater than that of the wild type enzyme in T cells.
The quantitative effects of modulating Itk self-association on T cell receptor signaling
events (Fig. 4) are similar to those seen in studies of the Src family kinase, Lck.  Src kinases,
including Lck, are negatively-regulated by an intramolecular association between the SH2
domain and a phosphorylated tyrosine in the C terminal tail that is absent in the Tec kinases.
A comprehensive examination of Lck autoinhibition was recently reported in which this
intramolecular interaction is either disrupted or strengthened by sequence changes close to
the phosphotyrosine (34).  Lck-deficient Jurkat T cells were reconstituted with wild-type Lck
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or Lck mutants, and T cell receptor signaling leading to Erk activation was examined.
Similar to our findings for wild-type Itk and Itk(BtkSH3), modulation of the Lck autoinhibitory
interaction led to detectable, but modest changes in Erk activation.  Together these studies
indicate that shifting the equilibrium between active and inactive kinase conformations alters
the strength of TCR mediated signaling but does so within a limited range of outcomes.  This
is in contrast to mutations located in active sites that have pronounced, all or nothing, effects
on downstream signaling.
Specific intermolecular self-association has been characterized for a number of
protein systems (35).  Within the kinase superfamily this mechanism activates receptor
kinases by promoting trans auto-phosphorylation both within and outside of the protein
kinase domain (36).  In another example of activation by intermolecular association, the anti-
viral protein kinase PKR dimerizes via phosphotyrosine-dependent binding to double-
stranded RNA (37,38).  Alternatively, inhibition by dimerization occurs for the receptor-like
protein tyrosine phosphatase-a where an inhibitory ‘wedge’ on one molecule inserts into the
catalytic site of another molecule (39).  A crystal structure of the kinase domain from yeast
Snf1 also reveals a dimeric arrangement that putatively impedes catalytic activity by steric
means (40).  Likewise, a crystal structure of Ca2+/calmodulin-dependent protein kinase II
(CaMKII) reveals a regulatory segment that sterically blocks substrate binding to the
catalytic site (41).  The CaMKII kinase domain itself is intrinsically active and dimer
formation brings the regulatory segment into position to inhibit activity.
In light of these examples, a simple mechanistic model for Itk autoinhibition by self-
association would invoke steric blockage of the catalytic site.  However, it has been well
documented that the isolated Itk kinase domain exhibits little or no catalytic activity (22-24)
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suggesting the possibility of an alternative autoinhibition mechanism.  We have recently
reported a kinetic analysis of a series of Itk fragments and have shown that the SH2 domain
and linker between SH2 and kinase domains are required to achieve wild-type levels of
activity (22).   Like the Csk kinase (42), the SH2 and SH2-kinase linker region make direct
contact with the kinase domain to stabilize the active conformation of Itk.  Thus, inhibition of
Itk catalytic activity by SH3/SH2 mediated self-association could be explained if the
intermolecular interactions between Itk regulatory domains (particularly those involving the
SH2 domain) compete with activating interactions between the SH2 and kinase domains.
T cell activation itself produces signals that compete with the self-association
equilibrium and would shift the population of Itk in the cell toward a monomeric state.
Specifically, exogenous binding partners such as transiently produced phospholigands would
compete directly with Itk self-association by interfering with the SH2/SH3 interaction
interface (9,12,16,28,43,44).  If self-association is disfavored, the regulatory domains could
then adopt the catalytically competent conformation (22).  Conversely, in the absence of such
activating factors, Itk might remain self-associated and autoinhibited.
It is also possible to envision a role for Itk autoinhibition following activation of Itk
by TCR engagement; in this case, self-association would be one mechanism that could
terminate Itk signaling.  In detailed binding studies of the Itk SH3 and SH2 domains we
found that a mimic of Y180 phosphorylation in the SH3 domain enhances affinity for the Itk
SH2 domain (45).  Together with the observations that autophosphorylation at Y180 in the
SH3 domain has no effect on Itk kinase activity and occurs in cis (45) it is reasonable to
suggest that autophosphorylation may be a first step toward turning off Itk mediated
signaling, by promoting intermolecular self-association leading to a drop in kinase activity.
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Indeed, a previous report suggests that Itk clustering in T cells occurs following membrane
association (21).
While the precise mechanistic details of when and how intermolecular association of
Itk modulates its activity remain a question, this mode of autoinhibition for a non-receptor
tyrosine kinase suggests that reagents (or mutations) that shift the equilibrium toward the
self-associated state could dampen T cell activation while disfavoring self-association will
increase Itk activity and concomitant T cell activation.
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Figure Legends
Figure 1.  The Itk SH3/SH2 interaction is specific and mediates intermolecular self-
association of full-length Itk.  (a) Structures of both the Itk SH2 and SH3 domains have
been solved (11,13) and chemical shift mapping has been used to determine the residues at
the interface of the SH3/SH2 complex (light shading) (12). The classical pY and pY+3
binding pockets are labeled on the SH2 domain. (b) Myc and V5 tagged full-length Itk were
transiently transfected into NIH 3T3 cells (lane 1).  As controls, V5 tagged protein or
pcDNA3 vector alone (lanes 2 & 3, respectively) were transiently transfected into NIH 3T3
cells. In all three lanes, anti-myc antibody was used to precipitate myc tagged protein from
cell lysates; V5 antibody was used to detect V5 tagged protein that co-immunoprecipitates
with myc tagged protein (top panel).  The presence of V5 and myc-tagged proteins is
confirmed in the center and bottom panels. (c,d) Same experiment as in (b) using V5- and
myc-tagged kinase domain alone (c) or V5- and myc-tagged full-length Itk(BtkSH3) (d).
Figure 2. Specific disruption of the intermolecular SH3/SH2 interaction. (a) The Itk SH3
and Btk SH3 domain structures are superimposed (only labeled side chains from the Btk SH3
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domain are shown for clarity).  The Itk SH3/SH2 interaction surface is indicated in orange on
the SH3 structure (12).  Within this binding surface, only eight residues are not conserved
between Itk and Btk.  Each of the non-conserved pairs of residues are labeled and indicated
on the structure (orange are Itk side chains and red are Btk side chains).  (b) Select region of
heteronuclear single quantum coherence (HSQC) spectra of 15N-labeled SH3 domains (from
either Itk (top) or Btk (bottom)) indicating the chemical shift perturbations associated with
binding to unlabeled Itk SH2 domain.  The black spectrum is 15N labeled protein alone and
the red spectrum has been acquired following addition of equimolar unlabeled Itk SH2
domain in each case.  In the top panel the arrow indicates the change in resonance frequency
for a representative peak upon addition of Itk SH2 to 15N labeled Itk SH3 domain.  In the
bottom panel a representative region of the HSQC spectrum that results from addition of
unlabeled Itk SH2 domain to 15N labeled Btk SH3 domain show no chemical shift change
indicative of the absence of an interaction between Itk SH2 and Btk SH3. (c) Concentration
dependence of the normalized 1H chemical shift (Dd/Ddmax) for representative residues of
15N labeled Btk SH3 domain (top) and 15N labeled Itk SH3 domain (bottom) upon titration of
the Slp76 derived proline-rich peptide.  The titration data were acquired and analyzed as
previously described (15).  (d) Design of the Itk(BtkSH3) chimeric protein.  The Itk SH3
sequence within full-length Itk is replaced with the SH3 sequence of Btk.  The sequence of
the Btk SH3 domain is shown in bold below the domain map of Itk and the surrounding Itk
residues within the Itk(BtkSH3) chimeric construct are non-bold and underlined.
Figure 3. In vitro comparison of Itk(BtkSH3) and wild-type Itk.  Western blot analysis using
phosphotyrosine specific antibodies to the autophosphorylation site in the SH3 domain (a)
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and the activation loop tyrosine (b).  (a) Lane 1: wild-type full-length Itk, lane 2: full-length,
mutant Itk(Tyr180Phe) and lane 3: Itk(BtkSH3) were expressed as fusions with the flag peptide
and purified from insect cells, resolved by SDS-PAGE, transferred to PDVF membrane and
blotted with the Btk antibody to pY223 (Btk numbering; this tyrosine corresponds to Y180 in
Itk) to detect the autophosphorylation status in the SH3 domain (top panel).  Cross reactivity
of the Btk pY223 antibody for Itk pY180 has been previously demonstrated (9).  (b) Lane 1:
wild type full length Itk, lane 2: Itk(BtkSH3) were prepared as in (a) and blotted with the anti-
pY551 antibody to detect the activation loop phosphorylation status (top panel). Itk protein
levels are indicated in the bottom panel for both (a) and (b).  (c) Wild-type Itk activity
deviates from linearity at increased Itk concentrations.  Concentration dependence of initial
velocity, Vi (mM/min) for wild-type full-length Itk (closed squares) and Itk(BtkSH3) (open
diamonds).  The linear increase in initial velocity as a function of concentration for Itk(BtkSH3)
is indicated by the solid line. Experiment was carried out in duplicate and the data shown are
representative of three independent experiments.
Figure 4.  Increased activity of Itk(BtkSH3) versus wild-type Itk in insect cells and T cells.
(a) Full-length wild-type Itk (lane 1) or Itk(BtkSH3) (lane 2) were co-expressed with PLCg1 in
Sf9 insect cells.  After three days, cell lysates were prepared, and immunoblotted for
phospho-PLCg1 (top panel), total PLCg1 (middle panel) or Itk (bottom panel).  (b) Itk-/-
primary CD4+ T cells were infected with the retrovirus vector alone (MSCV, solid line), a
retrovirus expressing wild-type Itk (Itk, long dashed line) or a retrovirus expressing Itk(BtkSH3)
(short dashed line); GFP+ cells were sorted on day 4 post-infection.  Histograms of GFP
fluorescence are shown compared to unstained cells (filled histogram).  Cells were stimulated
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with anti-CD3 antibody for 5 minutes, fixed, permeabilized, and stained with anti-phospho-
ERK antibody.  The percentages of phospho-ERK+ cells are indicated on each histogram.
(c) The graph shows data from three experiments in which Itk-/- primary CD4+ T cells were
infected with retrovirus vector alone (MSCV), retrovirus expressing wild-type Itk (Itk), or
retrovirus expressing Itk(BtkSH3).  GFP+ cells were sorted, stimulated with anti-CD3 antibody
as in (b), and analyzed for ERK activation.  Bars indicate mean±S.D. of the percentage of
phospho-ERK+ T cells. *, p<0.0005; **, p<0.0006; ***, p<0.004.  (d) Itk-/- primary CD4+ T
cells were infected with the retrovirus vector alone (lane 3), a retrovirus expressing wild-type
Itk (lane 4) or a retrovirus expressing Itk(BtkSH3) (lane 5); GFP+ cells were sorted on day 4
post-infection. Cells were stimulated with anti-CD3 antibody for 5 minutes, lysed, and
immunoblotted for Itk (top panel), phospho-ERK (middle panel) and total ERK (bottom
panel).  Lanes 1 and 2 represent primary Itk+/+ CD4+ T cells stimulated with anti-CD3










CHAPTER 6. GENERAL CONCLUSIONS
Summary
Itk is a tyrosine kinase that is implicated in the T cell signal transduction and
cytoskeleton reorganization after TCR engagement (1).  It is well established that Itk needs to
be recruited to the plasma membrane and transphosphorylated by Lck to be activated (2, 3).
However the detailed mechanisms that regulate Itk kinase activity are still elusive.  Itk
consists of a PH domain, proline rich region, and a SH3, SH2 and kinase domain.  Our group
previously reported that the Itk SH3 domain can interact with Itk SH2 domain leading to self-
association of the large fragment that includes both the SH3 and SH2 domains (4).  In this
thesis, I have extended this observation to the full-length Itk molecule.  A full-length Itk-SH3
mutant that exhibits decreased self-association was constructed by replacing the Itk SH3
domain with the Btk SH3 domain.  In vitro kinase assays indicate that the wild type full-
length Itk kinase activity decreases at higher protein concentration while kinase activity of
the Itk-SH3 mutant increased linearly with increasing enzyme concentration.  When
coexpressed with PLCg1 in insect cells, the full-length Itk-SH3 mutant phosphorylates
PLCg1 to a greater extent than does wild type full-length Itk.  Furthermore, expression of the
full-length Itk-SH3 mutant in primary T cells leads to higher ERK phosphorylation following
TCR stimulation than wild-type Itk.  Our data suggest that the tyrosine kinase Itk can be
down regulated by intermolecular self-association.
PLCg1 is the substrate for Itk in T cells (2).  After the TCR engagement, Itk is
activated and phosphorylates its substrate PLCg1.  Activated PLCg1 hydrolyzes PIP2 into IP3
and DAG, which mobilize Ca2+ release and activate PKC respectively (5 - 7).
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Phosphorylation is required for PLCg1 activation.  However, the mechanism by which
PLCg1 is specifically phosphorylated by Itk is not clear.  In this thesis, I discover that a
docking interaction is necessary for efficient phosphorylation of PLCg1 by Itk (8).
Interestingly, a similar docking interaction is required for autophosphorylation in the Itk SH3
domain (8).  Further studies indicate that the docking interaction is mediated by the Itk kinase
domain and a portion of the substrate SH2 domain. This docking interaction is different from
typical SH2 domain mediated interactions as it does not involve phosphor-tyrosine binding
pockets of SH2 domain and nor does it involve phosphorylation of the Itk kinase domain.
The docking interaction enhances Itk mediated phosphorylation by ~7 fold by increasing the
affinity between the Itk kinase domain and its substrates.  Furthermore, the Tec family
kinases are conserved in exploiting this docking interaction to phosphorylate their substrates.
The docking interaction provides a possibility to selectively target the enzyme-
substrate interaction surface instead of the enzyme catalytic site to modulate enzyme activity.
The structural basis for the docking interaction is not yet completely understood.  Site-
directed-mutagenesis was used to map out the docking site on the PLCg1 SH2C.  We found
that the docking site on the PLCg1 SH2C is composed of a largely basic surface from the BG
loop and CD loop of the SH2C.  Consistent with the location of the docking site on the
SH2C, the presence of phosphor-tyrosine ligand does not interfere with the interaction
between the Itk kinase domain and the PLCg1 SH2C.  Furthermore the docking site that is
mapped out in the SH2C domain fragment can be extended to full-length PLCg1.  The
presence of excess wild type PLCg1 SH2C domain in an in vitro kinase assay, but not the
SH2C docking mutants, can decrease the phoshporylation of full-length PLCg1.  Mutation of
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the residues that are involved in the docking interaction in the full-length PLCg1 substrate
diminishes the phosphorylation by Itk.  Our data indicate that the docking interaction is
required for the full-length PLCg1 phosphorylation by Itk.
We also found an intramolecular interaction between the PLCg1 SH2C and the
adjacent linker that can modulate the docking interaction between SH2C and Itk kinase
domain.  Biochemical and NMR spectroscopic analyses indicate that the intramolecular
interaction is different from the canonical SH2/phosphor-tyrosine interaction. Residues in the
SH2C domain that mediate linker binding form a hydrophobic groove that overlaps with the
canonical pY+3 binding pocket.  Our data suggest that the intramolecular interaction might
be one of the mechanisms that keep PLCg1 in its inactive conformation before its
phosphorylation and activation.  Overall this thesis provides significant molecular level
insight into mechanisms of the substrate recognition by Itk and regulation of TCR signaling.
Future directions
Substrate docking and its regulation by PLCg1 intramolecular interaction
The novel substrate docking interaction interface on the SH2 domain has been
mapped, but the interaction surface on the Itk kinase domain is still unknown.  The nature of
the residues on the surface of SH2C (basic) suggested an acidic patch in the Itk kinase
domain could be responsible for the binding.  Inspection of the Itk kinase domain structure
reveals a potential acidic patch in the small lobe of the kinase that will be the target of future
mutational analysis.  The structural information about the interaction surface could provide
clues for designing specific inhibitors for the substrate docking interaction.
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In my research here, I also discovered a novel intramolecular interaction between the
PLCg1 SH2C and the adjacent linker.  This intramolecular interaction likely occurs prior to
the phosphorylation of PLCg1 and is not dependent on phosphotyrosine.  We propose that
this intramolecuar interaction is one of the mechanisms that keep PLCg1 in its inactive
conformation before its phosphorylation and activation. To date, our investigations of PLCg1
regulation have focused on protein fragments.  One line of future studies will include
identifying mutations that break up the intramolecular interaction in the SH2C-linker
fragment, introducing these mutations into the full length PLCg1, and then measuring the
phosphorylation level of Y783 and the phospholipase activity of the full length PLCg1.
Based on my fragment studies, the intramolecular interaction between the PLCg1
SH2C and the adjacent linker can also regulate the substrate docking interaction based on a
pull-down assay.  Quantitatively studying the affinity differences between SH2C/Itk kinase
domain and SH2C-linker/Itk kinase domain will help us understand the extent of this
regulation.  Because of the challenges associated with obtaining sufficient amounts of the Itk
kinase domain, we have not yet been successful in using Isothermal Titration Calorimetry
(ITC) to measure the affinity between the PLCg1 SH2C and the Itk kinase domain.  Surface
Plasmon Resonance (SPR) is another technique that requires less protein and therefore might
be a good alternative technique to study these protein-protein interactions.
Solving the structure of the intramolecular SH2C-linker complex will provide a
structural basis for understanding the regulatory role of this non-classical interaction.  We
have tried to solve this complex structure by NMR spectroscopy.  13C, 15N double-labeled
SH2C-linker has been made and a series of spectra have been acquired for this protein: 15N-
editted NOESY, 15N-editted TOCSY, 13C-HCCH-TOCSY, HNCA, HNCOCA, HNCACB
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and CACBCONH.  But because of exchange broadening (likely due to the dynamics of the
SH2C/linker association), many of these spectra are incomplete.  By comparing NOESY
spectra of isolated SH2C and SH2C-linker, I am able to assign the backbone resonances of
most residues of the SH2C portion in the context of SH2C-linker.  Complete assignment will
be needed for structure determination.  The following strategies will be tried to improve the
quality of the NMR spectra. We will try a different pulse sequence to suppress relaxation
during transfer.  As well, we are designing mutants to enhance the affinity between the linker
region and the SH2C domain so that the dynamic exchange rate might be modified.  Based
on our truncation and mutation data, we know that the last four residues in the linker region
A786NPM789 are associating with the residues from the SH2C domain, which form a large
hydrophobic groove.  A series of mutants will be made to screen for a mutant that has higher
affinity between the SH2C domain and the linker. GST pull-down assays will be used for this
screen.  For the mutants that have higher affinity for the SH2C, we are expecting to see
diminished interaction with the Itk kinase domain.  For the promising mutants, 15N-labeled
protein will be made and 15N edited TOCSY will be acquired.  Chemical shift difference
between the mutant and the isolated SH2C will be analyzed to make sure the SH2C residues
in the mutant are associating with the linker in the similar manner.  When an appropriate
mutant is available, a series of NMR spectra can be acquired for assigning resonances and
then the structural determination of the mutant will be feasible.
Itk self-association and its regulation of Itk kinase activity
In the Chapter 5, I found an Itk-SH3 mutant that diminishes the self-association of Itk
downregulates the Itk kinase activity. Significant effort has been spent on biophysical
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characterization of the wild type Itk and Itk-SH3 mutant. Unfortunately it has been difficult
to achieve sufficient concentrations of these proteins for detailed studies. Both proteins self-
associate and form higher order aggregates based on native gels.   Recently, it is reported that
the Itk PH domain could dimerize or self-associate (9, 10), which provides another direction
to further control the aggregation status of this protein.  Along these lines, if we can identify
some residues in the Itk PH domain that are mediating PH domain self-association, and
combine the mutation of these residues and Itk-SH3 mutations, it will be possible to further
shift the equilibrium toward monomeric full-length Itk.
This thesis provides significant insight into the mechanism of substrate docking and
negative regulation of Itk function.  It also provides a foundation for continued effort to
understand the regulation of TCR signaling and structural basis for both the substrate
recognition and inhibition of Itk catalytic activity.
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